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INTRODUCTION  
  In the early twentieth century, Mosher said that intranasal 
ethmoidectomy is one of the most dangerous and blindest of all surgeries. 
This view changed dramatically with the advent of the endoscopes. 
Throughout the history of medicine numerous attempts have been made to 
illuminate and examine the inside of the various hallow cavities located 
within the body.  
  In 1907, Hirschmann used a modified cystoscope to examine the 
middle meatus and study sinus ostia 1. The most significant development in 
nasal endoscopy was noticed during 1950’s when Hopkins developed solid 
rod lens with proximal cold light source. In the latter part of twentieth 
century sinonasal endoscopy has been established as an important 
component in our diagnostic and therapeutic armamentarium 2.  
  The pioneering work of Prof Walter Messerklinger of Graz, Austria 
on the mucosa of paranasal sinuses and the muco-cilliary transport, has 
brought light into the understanding the pathophysiology of sinus diseases. 
This can be summarized as below:  
  1. Most PNS infections spread from nose to sinus.  
  2. Recurrent sinusitis is secondary to insufficient outflow or 
obstruction of the natural sinus ostia into the nasal cavity.  
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  3. Sites of obstruction or partial stenosis are the ethmoid 
infundibulum at the entrance to the maxillary and frontal sinus.  
  This work of Messerklinger has been appreciated and accepted. The 
earlier concept that frontal and maxillary sinuses are the culprits for 
chronicity of the disease is no longer accepted. This point was again 
confirmed by the introduction of CT-scan.  
  Modern endoscopic sinus surgery is arbitrarily divided into 
Messerklinger and Wigand approaches. The ideal approach for disease 
involving the anterior ethmoids, may or may not involving the maxillary 
and frontal sinus is Messerklinger approach(1985) which is from anterior to 
posterior.If the sphenois sinus, posterior ethmoids and frontal are involved, 
procedure can be extended. The Wigand approach (1978) in contrast to 
above, is ideal for patients with pansinusitis who may not respond to 
limited surgery.It involves routinely clearance of disease in all sinuses in a 
posterior to anterior approach. 
 FESS has gained popularity and continues to do so among the ENT 
surgeons in the recent years with the better understanding of the lateral wall 
of the nose. The present study is an attempt to assess the effect of FESS on 
the  symptom  profile of patients with chronic rhinosinusitis before and 
after surgery.  
  Chronic rhinosinusitis is one of the most frequent otolaryngologic 
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diseases encountered in routine ENT practice. The diagnosis of chronic 
rhinosinusitis is made by a variety of physicians including primary care 
physicians, general physicians, pediatricians, pulmonologists and 
otolaryngologists. Chronic rhinosinusitis significantly impacts the quality 
of life by interfering with the general health, vitality and social functioning 
and cause decrease in productivity in the work force, which is comparable 
with that observed in patients with coronary heart disease and chronic lung 
disease.  
  Chronic rhinosinusitis is one of the commonest conditions for which 
antibiotics are prescribed. Most cases of chronic rhinosinusitis respond to 
medical treatment but if no improvement in symptoms is achieved, FESS 
advocates systematic approach to the surgical treatment of the disease of 
the nose and sinuses.  
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AIM AND OBJECTIVES  
  1) To assess the various symptoms of Chronic Rhinosinusitis before 
FESS.  
  2) To compare the various symptoms of Chronic Rhinosinusitis 
before and after FESS.  
  3) To confirm FESS as a standard treatment modality in Chronic 
Rhinosinusitis  patients refractory to medical treatment. 
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REVIEW OF LITERATURE  
   
According to Draf 1, Hirschmann performed the first attempts at 
nasal and sinus endoscopy in 1907 using a modified cystoscope. In 1925 
Maltz, a New York rhinologist coined the term sinoscopy and advocated 
the technique for diagnosis of rhinosinusitis. In 1978, Messerklinger 
published the first systematic and detailed work documenting endoscopic 
findings in English. Messerklinger noted that wherever two mucosal layers 
came in contact, localized disruption of mucociliary clearance occurs 
causing retention of secretions in the area of contact, and thus creating 
increased potential for infection even in the absence of ostial closure. 
Anatomically, areas of mucociliary contact are most likely to occur in the 
narrow mucosa- lined channels of the middle meatus and the ethmoid air 
cell system. Messerklinger identified ventilatory defects in the middle 
meatus & anterior ethmoidal cells in patients with chronic and recurring 
sinus infections.  
  These areas of persistent mucosal contact occurred either as a result 
of mucosal inflammation and hyperplasia following an infection, or as a 
result of an anatomic malformation. In majority of the cases infection first 
involves the ethmoids which later on affects the maxillary sinus and frontal 
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sinus . So even severe mucosal diseases in the maxillary and frontal 
sinuses, which in the past had often been considered irreversible, usually 
resolved when normal ventilation and mucociliary clearance was restored 
and ethmoid disease was eradicated .  
  The infections of the paranasal sinuses mostly of rhinogenic in origin 
which spreads from nose onto the sinuses which was evident after years of 
experience with endoscopes and observations.   
 In case of recurrent rhinosinusitis the most common infective focus 
being the anterior ethmoids specifically the infundibulum which spreads to 
other sinuses and the cure entirely depends on its prevailing 
pathophysiology.   FESS aims at the primary focus in the anterior 
ethmoids, clearing the stenotic clefts and infected ethmoid cells. The 
maxillary ostium is enlarged into nasal fontanellae to provide drainage and 
ventilation. Fenestration in the inferior meatus is not necessary. Once 
ethmoidal focus is cleared, the dependent larger sinuses usually heal 
without having been touched even if their mucosal pathology seemed 
almost irreversible .  
  The use of FESS has become popular with the improvement in 
understanding the anatomy of the lateral nasal wall and the surgical 
technique.  
  Professor Messerklinger and Wigand introduced FESS in 1960’s. In 
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Europe it was popularized  by Stammberger, and  by Kennedy in 
NorthAmerica.  
  It has been accepted that for treatment of refractory CRS, FESS is the 
technique which is minimally invasive. FESS restores sinus drainage, 
improves mucociliary clearance and reverts the sinus function to normal.  
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ANATOMY OF LATERAL WALL OF THE NOSE AND PNS  
A) DEVELOPMENTAL ANATOMY  
I) LATERAL WALL OF THE NOSE  
  The complicated relationships of the lateral wall of the nose can be 
better understood if its embryologic development is first considered. As 
shown by Zukerkandl and others, the ethmoid turbinate originate from 
ridges in the lateral wall of the fetus in the 9th to 10th weeks. Six major 
furrows (S1-S6) develop that may be reduced by fusion to 3 to 4. These 
furrows are separated by ridges, that have an anterior portion (ramous 
ascenders) and posterior, inferior and more horizontal portion (ramous 
descendents) . 
     
Fig : Embryology of the lateral nasal wall 
(S1 to S6-Furrows, ET-Ethmoturbinals, MT-Maxilloturbinals, 
NT-Nasoturbinals, TO-Tubal opening)  
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  The complex ethnocide labyrinth of the adults can be reduced into a 
series of lamellae based on embryologic precursors. The significance of 
these embryologic structures is appreciated during the endoscopic sinus 
surgery as they are encountered from anterior to posterior. The first basal 
lamella corresponds to uncinate process, the second basal lamella 
corresponds to ethmoid bulla, the third basal lamella corresponds to the 
base of middle turbinate and the fourth basal lamella corresponds to the 
base of the superior turbinate. The inferior turbinates are derived from the 
maxillo turbinals (MT), which represents an individual bone that has 
nothing in common with the ethmoturbinals (ET).  
Table : Development of the lateral wall of the nose 
  
FURROWS STRUCTURES DERIVED 
First furrow Frontal recess,  
Ethmoidal infundibulum,  
Middle meatus.  
 
Second Furrow Superior meatus 
Third furrow  Supreme meatus 
Fourth, fifth & sixth furrows Disappears 
 
 
10 
 
 
RIDGES STRCTURES DERIVED 
First ridge  
 
Agger nasi,  
Uncinate process 
Second ridge Middle turbinate 
Third ridge Superior turbinate 
Fourth & Fifth ridges Supreme turbinate 
 
   
1) PARANASAL SINUSES   
MAXILLARY SINUS  
  Maxillary sinus is the first to appear at 7-10 weeks as shallow 
grooves which expand into the mass of  maxilla originating from the 
primitive ethmoidal infundibulum. At birth it is about 7x 4x 4 mm 
pyramid shaped cavity filled with fluid. The growth of sinus is biphasic 
with growth during 0-3 yrs and 7-12 yrs at the rate of about 2mm vertically 
and 3mm anteroposteriorly. During the second phase (7-12 yrs), when the 
permanent teeth starts developing pneumatisation of the sinus spreads 
inferiorly. 
The sinus may be well pneumatised to the extent of just a thin layer 
of soft tissue covering the root of the tooth. In old age due to loss of teeth 
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there may be resorption of alveolus resulting in a relatively enlarged sinus. 
ETHMOID SINUS  
  The furrows in the lateral wall from the 3rd month of intrauterine life 
may be detected to be ethmoid cells. A few cells are present at birth, filled 
with fluid.  
  In the intra-uterine period the first cells to be formed are the anterior 
ones, later on posterior cells follow. Growth of the cells are gradual and by 
the age of 12 they reach the adult size. They can be seen in the radiography 
by age of one. As the child grows the pneumatization occurs by thinning 
out of the septa. Variations are common in ethmoidal cells the sites namely 
above the orbit (supra orbital 15%), lateral part of the sphenoids (Onodi 
cells 10%), involving the superior part/roof of maxillary sinus (Haller cells 
10%) & the frontal sinus involving its floor (frontal bulla). The above 
mentioned cells can obstruct and disrupt the normal sinus drainage. 
Preoperative imaging is a must to know the above common variations in the 
anatomy.  
   
FRONTAL SINUS  
  This sinus is regarded as anterior ethmoidal cell in relation to 
embryological development and the most common one with variations in in 
size & shape.A small frontal recess is recognizable from 3rd month of 
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intrauterine life, but upward expansion seldom occurs until after birth, 
when the membranous frontal bone starts to ossify from around 2nd yr of 
life. By 4 to 7 yrs lateral and medial expansion occurs and by 12 yrs the 
sinus expansion is almost complete. It is the last sinus to complete its 
development iin terms of growth.  
 
   
 
 
 
 
 
 
 
Fig : Development of the paranasal sinuses 
 
 
SPHENOID SINUS  
  It starts developing from the recess of sphenoethmoid by 3rd month 
of intra-uterine life. At birth, the fluid filled cavity measures 2x2x1.5mm; 
which reaches full size in adolescence and may expand further in old age. 
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0.25mm is the rate at which pneumatization occurs from 4 years of age 
which is not a constant one.  
 
B) MACROSCOPIC ANATOMY  
I) LATERAL WALL OF THE NOSE  
  The lateral wall of the nose has three prominent projections called 
turbinates. These are termed inferior, middle and superior turbinates. The 
spaces inferior to the turbinates are termed inferior, middle and superior 
meatus. 
     
        Fig : Anatomy of lateral nasal wall.  
 (SS-Sphenoid Sinus, PEC-Posterior ethmoid cell, SBR-Suprabullar 
recess, FS-Frontal sinus, AN-Agger nasi, EB-Ethmoid bulla, EI-Ethmoid 
infundibulum, UP-Uncinate process, MSO-Maxillary sinus ostium, 
IT-Inferior turbinate, BL-Basal Lamella, MT-Middle turbinate)  
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INFERIOR TURBINATE  
  It is a separate bone with firmly attached mucoperiosteum. 
Numerous vascular channels courses making grooves and perforates the 
bone making its surface irregular. The maxillary hiatus’ inferior  margin 
articulates with the maxillary process of inferior turbinate. 
  Nasolacrimal duct’s medial wall is formed by the articulation of 
inferior turbinate with palatine bone,lacrimal bone and ethmoid bone. It has 
a rich network of cavernous plexus submucosally having large sinusoids 
playing a role in nasal resistance with autonomic innervation. 
  
INFERIOR MEATUS  
  It is the largest meatus located in the inferolateral part of the inferior 
turbinate in the lateral wall involving the nasal cavity in its entirety in 
length with highest point located at the junction of anterior and middle 
third.  
NASOLACRIMAL DUCT  
  The lacrimal sac is drained by the naso-lacrimal duct. Its course 
starts from the lacrimal fossa runs down the posterior aspect of maxillary 
vertical buttress opening in the anterior part of the inferior turbinate.The 
opening is covered by a small fold of mucosa called plica lacrimalis [Valve 
of Hausner]. 4 to 9 mm anterior to the maxillay ostium lies the duct. 
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MIDDLE TURBINATE  
  The middle turbinate is part of the ethmoid bone. The most anterior 
and superior portion of middle turbinate is adjacent to crista ethmoidalis of 
maxilla, which produces an anterior bulge known as agger nasi. The 
posterior end of the middle turbinate is attached to the crista ethmoidalis of 
the perpendicular process of the palatine bone. The intervening area of 
insertion can be divided into three parts, the anterior third is entirely 
vertical and sagitally oriented inserting directly to the skull base at the 
lateral edge of the cribriform plate. In the middle third it is fixed to lamina 
papyracea by its ground lamella, where it runs in an almost frontal plane. In 
the posterior third, the almost horizontal ground lamella forms the roof of 
the most posterior section of the middle meatus and is fixed to lamina 
papyracea and/or to the medial wall of maxillary sinus. Posterior ethmoidal 
cells can indent the ground lamella antetiorly, and anterior ethmoid cells 
and retrobulbar recess can indent the ground lamella posteriorly.  
AGGER NASI  
  It is a mound/prominence on the lateral wall just anterior to middle 
turbinate insertion. Frequently pneumatized by an agger nasi cell that arises 
from the superior aspect of the infundibulum. An enlarged agger nasi cell 
may impinge on frontal sinus, narrowing the frontal recess.  
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MIDDLE MEATUS  
  Inferolateral part of the middle turbinate in the lateral wall lies the 
middle meatus  receiving  drainage from frontal sinus, maxillary sinus 
and the anterior ethmoidal cells.  
UNCINATE PROCESS [latin: uncinatus-hook shaped]  
  It is a sickle shaped structure measuring about 3-4 mm wide, 1.5 –2 
cm long entirely sagitally oriented. It is attached anteriorly to the posterior 
edge of the lacrimal bone and inferiorly to the superior edge of the inferior 
turbinate. It has a posterior free margin, bordering the hiatus semilunaris. 
Superiorly, it may attach to lamina papyracea, roof of the ethmoid or 
middle turbinate. 
    
Fig : Hiatus semilunaris and Ethmoidal infundibulum.  
(SL-Sinus lateralis,EB-Ethmoid bulla, HS-Hiatus semilunaris,EI-Ethmoid 
infundibulum, UP-Uncinate process)  
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BULLA ETHMOIDALIS  
  It has the largest anterior ethmoidal cells which is prominent and 
constant located in the middle meatus. It varies with size and 
pneumatization (completely unpneumatized-torus lateralis). It may fuse 
posteriorly with the basal lamella or may have a space between them called 
sinus lateralis / retrobulbar recess, which drains medially through the hiatus 
semilunaris posterioris. It may reach upto the roof of the ethmoids 
superiorly that forms the posterior wall of frontal recess. If it does not reach 
the skull base a suprabulbar recess is formed between the skull base and 
superior surface of the bulla. Lateral boundary of the bulla is formed by the 
lamina papyracea.  
HIATUS SEMILUNARIS  
The anterior surface of the bulla ethmoidalis and posterior edge of 
the uncinate process forms a two dimensional space namely the hiatus 
semilunaris. This is also referred to as hiatus semilunaris anterioris. The 
ethmoid infundibulum is reached through this.  
ETHMOID INFUNDIBULUM  
  It is a three dimensional space connecting the natural ostium of the 
maxillary sinus to the middle meatus via the hiatus semilunaris. 
Infundibulum may extend anteriorly and superiorly to the frontal recess in 
about 14% of the cases. The uncinate process superiorly attaches to the 
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lamina papyracea forming the recessus terminalis where the infundibulum 
ends blindly. In this situation the frontal sinus will drain medial to the 
uncinate process but lateral to the middle turbinate.  
OSTEOMEATAL UNIT   
  Osteomeatal unit is a functional rather than an anatomic designation, 
a term coined by Naumann [1965] in discussing the pathophysiology of 
sinusitis.  
  This does not refer to a discrete anatomic structure, but rather to 
several middle meatal structures collectively, namely the uncinate process, 
ethmoid infundibulum, and ostia of the anterior ethmoid cells, maxillary 
sinus and frontal sinus .  
    
Fig : Osteomeatal unit (shaded area).  
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MAXILLARY SINUS OSTIUM  
  The natural ostium of the maxillary sinus is located at the superior 
aspect of its medial wall. It is located mostly either behind the uncinate 
process in its lower third or in the ethmoidal infundibulum in its posterior 
part. The actual size of the opening is smaller compared to the actual bony 
defect due to the mucosa covering this area.  
NASAL FONTANELLES  
  Just posterior to maxillary sinus ostium and inferior to lamina 
papyracea is the membranous wall called nasal fontanelles that separate the 
maxillary sinus from the nasal cavity. They lie immediately anterior 
(anterior fontanelle) and posterior (posterior fontanelle) to the inferior 
aspect of the uncinate process. The posterior fontanelle is much larger and 
more distinct than its anterior counterpart.  
  The fontanelles, especially the posterior may be perforated creating 
accessory ostia (20-25%). These accessory ostia are indicative of prior 
sinus diseases.  
FRONTAL RECESS  
  It is located in the anterosuperior most part of the middle meatus. 
The frontal sinus natural ostium opening into the recess is of hourglass 
narrowing. Multiple ostia are found in 10% of patients. The superior 
attachment of the uncinate process will determine the drainage pattern of 
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the frontal sinus .  
    
             Fig : Frontal recess.  
(FS- Frontal sinus, AN-Agger nasi, MT-Middle turbinate, MM-Middle 
meatus, FR-Frontal recess)  
 
SUPERIOR TURBINATE  
  It is a part of the ethmoid bone and is the smallest turbinate, situated 
about 1.25 cms below cribriform plate.  
SUPERIOR MEATUS  
 The space where the posterior ethmoid cells drain which lies in the 
inferolateral part of the superior turbinate. 
SUPREME TURBINATE  
  In 60-70% of individuals it lies above the superior meatus which is 
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well developed in only less than 20% through which the posterior ethmoid 
cells drain into superior meatus. 
SPHENOETHMOIDAL RECESS  
  The space which lies behind & above the superior turbinate where 
posterior ethmoidal cells and the sphenoid drains into this region. 
ANATOMIC VARIATIONS  
CONCHA BULLOSA  
  This is a pneumatized middle turbinate. When present the concha 
bullosa may obstruct the infundibulum.  
 
   
Fig : Concha bulosa (CB). 
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PARADOXICAL MIDDLE TURBINATE  
  This is middle turbinate with its convexity laterally as opposed to the 
usual medial convexity. A paradoxical middle turbinate may obstruct the 
infundibulum or the frontal recess.  
UNCINATE PROCESS  
  This may be medially or laterally rotated. When medially rotated, the 
uncinate process may be in contact with the middle turbinate, narrowing the 
middle meatus. The surgeon should be careful while incising the laterally 
rotated uncinate process to prevent entry into the orbit. At times, the 
uncinate process may be pneumatized causing narrowing of the 
infundibulum.  
 
BULLA ETHMOIDALIS  
  Over pneumatization of bulla ethmoidalis produces extensive 
contact areas with the middle turbinate causing obstruction in the 
mucociliary pathway.  
AGGER NASI  
  When well pneumatized the agger nasi cells impede the drainage of 
the frontal recess and should be removed to expose the frontal recess.  
HALLER CELLS  
  These cells develop along the floor of the orbit and may constrict the 
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posterior aspect of the ethmoid infundibulum.  
ONODI CELLS  
  The posterior ethmoid cells may develop both laterally and 
superiorly beyond the anterior wall of the sphenoid sinus. These 
posterolateral cells are called Onodi cells. It is important to recognize 
Onodi cells since dissecting posteriorly in this plane during surgery may 
lead to penetration of the skull base or damage the optic nerve.  
   
ARTERIAL SUPPLY  
  The anterior ethmoidal artery supplies the anterosuperior quadrant 
along with the posterior ethmoidal artery & facial artery. Anteroinferior 
quadrant is supplied by branches from the facial and greater palatine artery. 
The posterosuperior quadrant is supplied by the sphenopalatine artery and 
the posteroinferior quadrant is supplied by the branches of the greater 
palatine artery.  
VENOUS DRAINAGE  
  The veins form a plexus, which drains anteriorly into the facial vein; 
posteriorly into the pharyngeal plexus; and from the middle part, to the 
pterygoid plexus of the veins.  
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NERVE SUPPLY  
GENERAL SENSORY:  
  The anterosuperior quadrant is supplied by the anterior ethmoidal 
nerve, anteroinferior quadrant by the anterior superior alveolar nerve, 
posterosuperior quadrant by the posterior superior lateral nasal branches 
from the pterygopalatine ganglion, and posteroinferior quadrant is supplied 
by the anterior palatine branch from pterygomaxillary ganglion.  
SPECIAL SENSORY:  
  Special sensory nerves [olfactory] are supplied to the upper part of 
the lateral wall just below the cribriform plate upto the superior concha.  
LYMPHATIC DRAINAGE  
  Anteriorly lateral wall of nose drains into the submandibular lymph 
node, posteriorly into the retropharyngeal lymph nodes and upper deep 
cervical lymphnodes.  
   
II) PARANASAL SINUSES  
MAXILLARY SINUS  
  The adult maxillary sinus is a pyramid, which has a volume of 
approximately 15 ml. Its dimensions are 34x 33x 23 mm. The lateral nasal 
wall forms the base of the pyramid and the apex of the pyramid points in the 
direction towards zygomatic process. The infraorbital nerve runs over the 
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roof of the maxillary sinus and exits through the infraorbital foramen which 
is situated at the mid superior part of the anterior wall whose canal is 
dehiscent in 14% of subjects. Canine fossa that lies above the canine tooth 
is the thinnest part of the anterior wall. Orbital floor forms the roof and 
behind the posterior wall is pterygomaxillary fossa. The level of the floor 
varies with age lying above the nasal floor till 9 yrs of age,at the nasal floor 
level at 9 yrs of age and extends down as age advances and pneumatization 
increases.   
ARTERIAL SUPPLY  
  The arterial supply is by infraorbital A, lateral branch of 
sphenopalatineA, greater palatine A and superior alveolar artery.  
VENOUS DRAINAGE  
  Venous drainage is to the facial vein anteriorly and maxillary vein 
posteriorly.  
NERVE SUPPLY  
  Nerve supply is through the greater palatine nerve and branches of 
the infra orbital nerve.  
   
ETHMOID SINUS  
  The anterior and posterior ethmoid cells have a combined volume of 
about 15 ml. Its dimensions are 33x 27x 14 mm. They are shaped like a 
 
 
26 
 
pyramid with the widest base posteriorly towards the sphenoid and apex 
anteriorly. Thin septae divide the ethmoid cells into multiple ones. The 
ethmoid roof slopes inferomedially and is thin medially than laterally (by a 
factor of 10). The lateral lamella of the cribriform plate forms the roof 
medially, which is variable in vertical height. Kero’s classified olfactory 
fossa into three types depending upon its depth,  
  1 to 3 mm deep – Type I  
  4 to 7 mm deep – Type II  
  8 to 16 mm deep – Type III  
 
Type III is said to carry the greatest risk of inadvertent intracranial injury.  
   
  The posterior aspect of the ethmoid cells borders the sphenoid sinus, 
and the lateral wall is formed by the lamina papyracea.  
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Fig : Kero’s classification 
ARTERIAL SUPPLY  
  It is supplied by the sphenopalatine and ophthalmic arteries.  
VENOUS DRAINAGE  
  Follows the arterial supply and thus can carry infection 
intracranially.  
NERVE SUPPLY  
  Ophthalmic (V1) and Maxillary branches (V2) of the trigeminal 
nerve. V1 supplies the superior aspect and V2 the inferior aspect.  
  .  
ETHMOIDAL ARTERIES AND VEINS   
  The ethmoidal arteries arise from the ophthalmic artery, a branch of 
the internal carotid. The anterior ethmoidal artery passes through the 
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anterior ethmoidal artery canal in the medial orbital wall, usually at the 
junction of the frontal bone and lamina papyracea, traverses the roof of the 
ethmoid, passes through the vertical attachment of the middle turbinate 
where it abuts the base of the skull and reaches the superior surface of the 
cribriform plate where it gives a meningeal branch. The artery then passes 
down to supply the upper nasal septum and lateral wall of the nose, sending 
a terminal branch to the nasal dorsum between the nasal bones and upper 
nasal cartilages. The artery crosses the roof of the ethmoid just posterior to 
the frontal recess and may run in a dehiscent canal or in a mucosal fold. The 
artery enters the anterior cranial fossa medially and at this point it may be 
readily breached. In 14% of subjects the anterior ethmoidal artery may be 
absent unilaterally; in 2% of subjects it may be absent bilaterally and in 
30% it may be multiple. 
     
Fig : Anterior ethmoidal arteries 
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  Posterior ethmoidal artery branch may replace if in case there is 
absent anterior ethmoidal artery. The smaller posterior ethmoidal artery 
runs through the canal in the medial wall of orbit to supply the posterior 
ethmoidal cells, and gives a meningeal branch, and terminates in the nasal 
branches anastomosing with the sphenopalatine artery. The ethmoidal 
veins drain into the ophthalmic veins following the arteries.  
FRONTAL SINUS  
  This sinus has a volume of approximately 6-7 ml. It measures about 
28x 24x 20 mm. Frontal sinus is bilateral,funnel shaped with high 
variations in antomy and it points upwards, the ostia opening in the 
posteromedial part(dependent portion). Both walls are diploic with a 
thinner posterior wall.    
ARTERIAL SUPPLY  
  Is by the ophthalmic artery via the supraorbital and supratroclear 
artery.  
VENOUS DRAINAGE  
  Is by the ophthalmic vein to the cavernous sinus , and the posterior 
wall has small venules that drain into sinus of dura. 
NERVE SUPPLY  
  By the supra orbital and supra trochlear nerve.  
SPHENOID SINUS  
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  It has a volume of about 7.5 ml and dimension of 23x 20x 17mm.  
  Pneumatization is variable and is accordingly classified into three 
types, Conchal type: The pneumatization is limited to the area of the 
attachment of the superior concha. This type of sphenoid is a 
contraindication for pituitary surgery.  
  Pre-sellar type: The pneumatization does not extend beyond a plane 
perpendicular to sellar wall.  
  Sellar type: This is the most common and here the pneumatization 
extends into the body of the sphenoid below the sella and may extend as far 
posteriorly as the clivus.  
  The anterosuperior wall and roof are thinner than the other walls. 
Within the sphenoid sinus two projections are visible in the lateral wall of 
the sinus, the optic nerve above and the internal carotid artery below. In 
about 25% of the cases the carotid artery may be totally or in part dehiscent. 
Dehiscence of the optic nerve is present in 6 % of the cases. The anterior 
wall of the sphenoid sinus is approximately 7 cms from the anterior nasal 
spine at an angle of 30 degrees to the floor. In the roof of the sphenoidal 
sinus there is a convex bulge produced by the pituitary fossa.  
ARTERIAL SUPPLY  
  Posterior ethmoidal and sphenopalatine arteries supply the sphenoid 
sinus.  
 
 
31 
 
VENOUS DRAINAGE  
  This is by the maxillary vein and the pterygoid venous plexus into 
the jugular veins.  
NERVE SUPPLY  
  Are by the nasociliary N, posterior ethmoidal N and a branch of the 
sphenopalatine nerve. 
 
C) MICROSCOPIC ANATOMY 
  The sinuses are lined with pseudostratified ciliated columnar 
epithelium. It has basal cells, ciliated cells and  non- ciliated columnar  
cells,goblet cells. Ciliated columnar epithelial cells have about 200 cilia, 
which beat towards the ostia of the sinuses, moving the mucous secretion 
towards the sinus ostium. Each cilia have microtubules and dynein arms. 
Non-ciliated epithelial cells have microvilli. They increase the surface area 
which helps in humidification and warming of inspired air. Basal cells act 
as stem cells and differentiate when need arises. Goblet cells are innervated 
by sympathetic and parasympathetic nerve fibres. They produce 
glycoprotein, which forms the major content of mucous. This glycoprotein 
determines the viscosity and elasticity of mucous.thus parasympathetic 
stimulation leads to thick mucous secretion and sympathetic stimulation 
causes watery one. Epithelial layer has a lamina propria below that 
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comprises of serous and mucinous glands with basement membrane above 
and periosteum below. Goblet cells are numerous in maxillary sinus and 
seronucinous glands are concentrated around the sinus ostia. 
   
PHYSIOLOGY--MUCOCILIARY CLEARENCE OF THE 
PARANASAL SINUSES  
  The ciliated cells in each sinus beat in a specific direction. Mucus 
flows in a specific pattern. The mucociliary transport of  mucous occurs 
with a genetically predetermined fashion. The transport is always towards 
the natural ostia and a dependent opening like intranasal antrostomy does 
not necessarily help in drainage of the sinus rather it may result in a cycle of 
mucous draining through the natural ostium again enters the sinus through 
the opening that was created. Mucosa contact between two adjacent areas 
arrests the mucociliary transport leading to stagnation and subsequent 
infection. Restoration of good mucociliary transport defines the clearance 
of the disease in the sinuses. 
 Mucociliary clearance in the frontal sinuses advances along the sinus 
roof, and then moves laterally along the roof and medially along the floor 
towards the ostia. Backflow, resulting from re-circulation in frontal recess, 
may be a cause of initial infection. In the maxillary sinus, mucociliary 
movement is towards the ostium. It starts at the floor and radiates along the 
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wall of the sinus superiorly.  
  Even after creation of antral windows during inferior meatotomy 
mucociliary movements persists in its upward direction towards the natural 
ostium. The frontal and maxillary sinuses are dependent sinuses, 
subordinate to their prechambers in the ethmoid and lateral nasal wall.  
    
PATHOPHYSIOLOGY OF SINUS INFECTION  
  Drainage and ventilation of the larger sinuses are essential to the 
maintenance of their normal functions. The ventilation and drainage of the 
maxillary and frontal sinuses pass through very narrow and complicated 
clefts before they reach the middle meatus. These clefts, the ethmoidal 
infundibulum and frontal recess respectively, are parts of the anterior 
ethmoid. The larger sinuses therefore are dependent on the health and 
proper functioning of these prechambers. Those disorders that produce any 
additional stenosis of these very narrow key areas may result in the contact 
of the mucosal surfaces with mucus retention. According to Naumann, a 
vicious cycle is initiated by the infundibular blockage. Interruption of 
ventilation and drainage caused by ostial obstruction leads to stagnation of 
the secretory products and damage to ancillary function of the respiratory 
epithelium with consequent inflammation. The inflamed mucosa in turn 
contributes to the ostial obstruction, thus completing the cycle.  
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  Despite the fact that the symptoms of infection in these larger sinuses 
are usually dominant symptoms, the underlying cause is generally not to be 
found in the larger sinuses themselves, but in the clefts of the anterior 
ethmoid in the lateral nasal wall. Messerklinger in his study noted that 
limited resection of the disease with the clearing the key areas of the 
anterior ethmoid, re-establishes the drainage and ventilation via the natural 
pathways. Even massive mucosal diseases in the dependent frontal and 
maxillary sinuses usually heal without direct intervention in these sinuses.  
   
CHRONIC RHINOSINUSITIS  
  Chronic Rhinosinusitis is an important and a most common disease 
in the health care problems that has a great impact on the physical quality of 
life which is comparable with chronic diseases like diabetes mellitus. It also 
causes impairment of the functional and emotional components of an 
individual. Extensive studies revealed that it occurs more common than 
arthritis & hypertension. 
  An insight into the aetiopathogenesis of CRS is of utmost importance 
for an effective treatment. The upper respiratory tract, lower respiratory 
tract, paranasal sinuses and middle ear cleft are in close relation with regard 
to anatomy and function which is the basis for the newer concept ‘one 
airway disease’. Disease involving one part may spread to the other. 
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Effective treatment of CRS may improve the lung function.  
Histopathologically, CRS is divided into two broad categories:  
  1) Polypoidal mucosal changes with eosinophilia, representing more 
severe damage.  
  2) Submucosal serous gland hyperplasia.  
The use of HPE in the diagnosis of CRS is not feasible. Tissue sampling is 
invasive not available to all physicians involved in CRS diagnosis and 
treatment.  
  Table : Factors associated with CRS  
SYSTEMICHOST 
FACTORS 
LOCALHOST FACTORS ENVIRONMENTAL  
FACTORS  
Allergy 
Immunodeficiency 
Genetic/congenital 
Mucociliary dysfunction 
 
 
Anatomic 
Concha bullosa 
Enlarged ethmoidal bulla 
Everted uncinate process 
Paradoxical middle 
turbinate 
Agger nasi cells 
Haller cells 
Deviated nasal septum 
 
 
Neoplastic 
Acquired mucociliary 
Microorganisms 
(bacteria,fungal,viruses) 
Toxic chemicals 
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 PATHOPHYSIOLOGY OF CRS  
1) Allergies and CRS  
  The causal relationship of AR to CRS is conflicting, although 
increased CRS associated with AR is observed. Cytokines and allergy 
mediated inflammation results in edematous sinonasal mucosa obstructing 
the natural ostia and impaired drainage resulting in secondary bacterial 
infection and their response to medical management is poor.   
2) Bacteria and CRS  
dysfunction 
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  Role of bacteria in CRS remains elusive. They may play a direct or  
indirect role in the development or perpetuation of CRS. Bacterial 
colonization of the sinuses may initiate an inflammation through 
non-infectious mechanism and disease persistence leading to chronicity.
 Bacteria found in association with CRS are peptostreptococus, 
propionibacterium spp, prevotella, streptococcal variants, cornybacterium 
spp, Haemophilus influenzae, pseudomonas spp, enterobacter spp 31.  
   
3) Fungi in CRS  
  Fungal colonization of the nose and PNS may be a common finding 
in both normal and diseased states because of the ubiquitous nature of the 
fungi. Under certain circumstances , fungal mycelia may get accumulated 
in the nose and sinuses forming fungal balls, saprophytic growth causing 
clinically apparent proliferation of fungus and the treatment modality 
involves complete removal of the fungal growth. In other cases the cause 
for the disease is the inflammatory response to the fungus.In these forms, a 
small amount of fungi results in clinically significant disease, 
demonstrating the ability of the fungal exposure to initiate a cascade of 
inflammatory events.The pathogenesis of CRS is of multifactorial in origin. 
CLINICAL FEATURES OF CRS  
  The criteria for Diagnosis of CRS is the presence of any two of the 
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major factors or any one major factor with any two minor factors. The signs 
and symptoms must persist for at least 12 consecutive weeks to qualify for 
CRS.  
               Table : Symptom Profile  
MAJOR CRITERIA MINOR CRITERIA 
Facial pressure/pain 
Nasal obstruction 
Purulent nasal discharge 
Post nasal drip 
Anosmia  
Fever (acute) 
Headache 
Halitosis 
Dental pain 
Cough 
Earache 
Ear fullness 
Fever(non-acute) 
 
Clinical examination  
External findings: swelling and erythema of the maxillary, ocular and 
frontal areas.  
Anterior rhinoscopy: hyperemia, edema, crusts, purulence, polyps, and 
changes in appearance after topical decongestion.  
INVESTIGATIONS OF CRS  
  Apart from the routine blood and urine examinations certain 
specific/special investigations are done namely nasal endoscopy, 
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radiographs, CT Scan, & MRI.  
A) Nasal Endoscopy  
  Nasal endoscopy is commonly used by otolaryngologist and can be 
helpful in the diagnosis of CRS. Nasal endoscopic findings in CRS may be: 
osteomeatal complex/sinus ostia purulence (fig 10), polyp (fig 11). Other 
associated findings are blue discoloration of mucosa, DNS, concha bullosa, 
paradoxical middle turbinate, and other physical/obstructive anomalies 34.  
B) Radiology: 
  The pre-requisite for surgical procedure is the complete information 
of anatomy of nose and paranasal sinuses and the extent to which the 
disease is involved  subsequently facilitates safe surgery with a 
well-defined “road map”.  
1) Radiographs: For frontal sinus and maxillary they are best demonstrated 
in AP view and Water’s view and for sphenoid sinus it is lateral view. The 
fine bony anatomy of the ethmoid sinuses, however, is poorly displayed on 
all views because of the problem of structural superimposition. Standard 
radiographs have a limited role in the evaluation of CRS.  
2) Computed Tomography:  
CT is the investigation of choice for the work up of diseases of the 
nose and paranasal sinuses . Its ability to optimally display bone, soft tissue 
and air facilitates accurate definition of the regional anatomy and extent of 
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the disease. The coronal plane is the best cut in ct that helps in the approach 
for surgery depicting both osteomeatal units and the relation of brain with 
that of the ethmoids and fovea ethmoidalis. The following parameters are 
used while performing this evaluation: Patient position: Prone with chin 
hyperextended.  
Gantry angulation: Perpendicular to bony palate.  
Extent of examination: From anterior frontal sinus through sphenoid sinus.  
Slice thickness: 3 mm.  
Table incrementation: 3 mm  
Field of view: Adjusted to include only the nasal cavity and PNS.  
Windowing: For soft tissue and air passages-start with window width of  
+2000 and a center of –200. Potentiometers are adjusted for best display of 
uncinate process and bulla ethmoidalis, and the images are recorded at this 
setting for the entire examination. For bone structures window width of 
+1500 and a center of +300 is used.  
3) Magnetic Resonance Imaging:  
 MRI has got its own limitations in evaluating the diseases involving 
sinus mucosa as it is difficult to distinguish normal mucosa from that of the 
inflammatory diseased one. Moreover it does not give a precise detail on 
osteomeatal units and their bony extension. It is not a preferred 
investigation for evaluating the disease process. 
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        X RAY PNS 
   
    
X RAY PNS SHOWING FRONTAL SINUSITIS 
For frontal sinus and maxillary they are best demonstrated in AP view and 
Water’s view and for sphenoid sinus it is lateral view. . Standard 
radiographs have a limited role in the evaluation of CRS.  
 
  
X RAY PNS SHOWING MAXILLARY SINUSITIS 
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ENDOSCOPIC VIEW OF THE NASAL CAVITY 
 
 
ENDOSCOPIC VIEW SHOWING MUCOPUS FROM MIDDLE 
MEATUS 
 
   
Nasal endoscopy is commonly used by otolaryngologist and can be helpful 
in the diagnosis of CRS. Nasal endoscopic findings in CRS may be: 
osteomeatal complex/sinus ostia purulence (fig 10), polyp (fig 11). Other 
associated findings are blue discoloration of mucosa, DNS, concha bullosa, 
paradoxical middle turbinate, and other physical/obstructive anomalies 
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Fig: Nasoendoscopic view of mucopus in middle meatus.  
   
  (MP-Mucopus, MT-Middle turbinate, NS-Nasal septum)  
 
 
 
Diagnostic Nasoendoscopy under local anesthesia to record the condition 
of nasal mucosa, septum, & inferior turbinates. To assess the condition of 
the nasopharynx and eustachian tube opening, to look for the presence of 
mucopus or polyp in the middle meatus/sphenoethmoidal 
recess/nasopharynx. Also, any co-existing anatomical variations of the 
lateral wall of the nose were noted.  
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Many patients with chronic rhinosinusitis will have a nasal endoscopic 
finding of polyps arising from the sinuses. It may be from the maxillary 
sinus or ethmoids- anterior and posterior or sphenoid sinus or frontal sinus. 
They may be associated with mucopus too. 
 
 
 
 
 Fig : Nasoendoscopic view of polyp arising from middle meatus.  
  (LNW-Lateral nasal wall, P-Polyp, NS-Nasal septum)  
 
  
 
 
45 
 
The below NCCT PNS of a chronic rhinosinusitis patient shows opacity 
which is complete involving the anterior and posterior ethmoids bilaterally. 
It is associated with mucosal thickening involving the left maxillary sinus.  
Sphenoid and Frontal sinuses are not seen in this coronal cut. 
 
 
 
Fig : NCCT of the nose and PNS - bilateral ethmoidal polyposis.  
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At present Non Contrast Computed Tomography is the investigation of 
choice for evaluating chronic rhinosinusitis. In our study it done for all the 
patients prior to the surgery for knowing the anatomic details of nose and 
paranasal sinuses. 
 
 
 
 
Fig : Non-contrast computed tomography of the nose and PNS - bilateral 
ethmoidal and maxillary sinusitis.  
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TREATMENT OF CRS 
1) Antimicrobial agents: Antimicrobial agents used for CRS therapy should 
be effective against both aerobic and anaerobic BLPB; these agents include 
the combination of a penicillin (e.g.: amoxycillin) and a beta – lactamase 
inhibitor (clavulanic acid), clindamycin, chloramphenicol; the combination 
of metronidazole and a macrolide and newer quinolones (e.g.: 
gatifloxacin). All these are available in oral and parenteral forms. If aerobic 
gram negative organisms, such as Pseudomonas aeruginosa are involved, 
parenteral therapy with an aminoglycoside, a fourth generation 
cephalosporin (cefepime or ceftazidime), or oral or parenteral treatment 
with a fluoroquinolones (only in post pubertal patients) is added. Parenteral 
therapy with a carbapenem (imipenem) is more expensive but provides 
coverage for most potential pathogens, both anaerobes and aerobes. The 
length of therapy is at least 21 days, and may be extended up to 10 weeks. 
Fungal sinusitis can be treated with surgical debridement of the affected 
sinuses and antifungal therapy (e.g.: fluconazole).  
2) Decongestants: Decongestants are important in the treatment of CRS, to 
diminish local mucosal edema and to improve access for air and egress for 
secretions via the sinus ostia. These alpha-adrenergic agonists may be 
administered either topically or systemically.  
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Topical decongestants: Long acting nasal preparations such as 
oxymetazoline, which can be administered twice daily, possess the 
advantage of direct application and relative freedom from systemic effects 
(when used in normal dosage). Nasal decongestant sprays or drops can 
however produce rebound mucosal congestion when administered for 
periods longer than 5 to 7 days. Hence, topical decongestants should be 
avoided in the long- term management of sinusitis.  
Systemic decongestants: The most commonly used systemic decongestants 
are pseudoephedrine and phenylpropanolamine. Their actions are similar 
and both possess the potential for producing the side effects due to alpha- 
adrenergic stimulation: nervousness, insomnia, tachycardia and 
hypertension.  
3) Mucolytics: One of the main symptoms of CRS is purulent nasal 
discharge and postnasal drip. To liquefy these secretions, both to aid in 
evacuation of sinus contents and to increase patient comfort, a systemic 
mucolytic agent is beneficial. The most widely used, and probably most 
effective, mucolytic for the treatment of CRS is guaifenesin. This 
preparation acts as an effective emetic in large doses, and to be effective as 
mucolytic, it must be administered in doses that are only subemetic (2400 
mg of total daily dose) .  
4) Nasal Toilet: Saline nasal sprays or irrigations can be used in cleansing 
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thick nasal and sinus secretions. To augment the mucolytic effects of saline, 
an alkaline, aromatic solution such as alkalol can be added to the saline in 
roughly equal parts. A variation in nasal toilet is the delivery of warm saline 
into the nasal cavity via a powered, pulsing irrigating device such as 
Grossan nasal irrigator. This is not only helpful in patients with thick nasal 
secretions but also helpful for postoperative cleansing following intranasal 
sinus surgery. Some relief of facial pressure can be obtained with the use of 
moist heat to the face and steam inhalation 39.  
5) Corticosteroids: It is one of the agents in medical management. 
Preoperative administration of steroids is used to minimize polyp size and 
reduce blood loss. Postoperative steroid pulses are used for recurrent 
disease. Because of their potent effects on many organ systems and their 
significant potential for undesirable side effects, systemic steroids are 
being largely supplanted by intranasal steroid sprays.  
Topical steroids: The role of nasal steroids in the treatment of sinusitis is to 
reduce edema of the osteomeatal complex. To be more effective, topical 
steroids must contact the mucosa in the desired area, which means that they 
will be less effective if the airway is obstructed by turbinate edema, severe 
DNS or large polyp. After the therapy is initiated, it is recommended that 
the patient be reexamined in 6 to 8 weeks to evaluate efficacy. Topical 
steroids in children have been shown to be safe, with no overall side effect. 
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Potential side effects are nasal irritation, crusting, bleeding, and septal 
perforation. Prolonged use of nasal steroids may produce local candidiasis. 
Various steroid preparations available for topical therapy are 
beclomethasone, budesonide, fluticasone and mometasone.  
6) Antihistamines: The mechanism of action is H1 receptor antagonist of 
competitive type that are present in nerve endings, glandular cells and 
smooth muscle cells of the blood vessels. They also have anticholinergic & 
antimuscaranic actions. In addition, they also possess local anaesthetic and 
antiserotonin effects. Patients with allergic component in their etiology can 
be benefited with this. The concern with antihistamines is the excessive 
drying of secretion leading to crust formation, and drowsiness. Side effect 
of drowsiness can be overcome with the use of newer second-generation 
antihistamines.Some of the antihistamines used are cetrizine (10 mg 
OD/BD), terfenadine (120 mg/day), fexofenadine (120 mg), Astemizole 
(10 mg OD) 39.  
7) Cromolyn: Cromolyn glycate stabilizes the mast cells by inhibiting the 
calcium-dependent degranulation process and favoring the accumulation of 
c-AMP. Cromolyn has the unique property of both preventing an allergic 
reaction and treating one that is underway, acting on both the acute and 
late-phase reactions. Because of the effect of priming, it is important for 
patients who have CRS with an allergic component to use cromolyn prior to 
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anticipated antigen challenge, as well as for symptomatic relief during 
allergy seasons.  
8) Immunotherapy: Immunotherapy involves the administration of 
carefully determined doses of inciting allergens over a period of years to 
incite the formation of IgG4 “blocking antibodies” which prevent the 
IgE-allergen-mast cell interactions that produces an allergic events.  
 
FUNCTIONAL ENDOSCOPIC SINUS SURGERY  
ANESTHESIA  
  The choice of anesthesia in FESS usually depends on the surgeon. 
Local anesthesia is often preferred as it is said to be safer and associated 
with less bleeding. Hypotensive general anesthesia has an advantage of 
controlled ventilation, reduced bleeding and pain. The sites of infiltration 
of the local anesthetic agent (2% lignocaine with adrenaline 1: 80,000) are 
uncinate process, bulla ethmoidalis, and root, head and posterior end of the 
middle turbinate. In cases of nasal polyps, the polyps too are infiltrated. It is 
important to wait for 10 min after infiltration before surgery is commenced.  
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Endoscopes ranging from 0 , 30, 70 degree are used for FESS. Specially 
designed instuments such as Blakesley forceps straight , and angled , 
reverse cutting forceps, turbinectomy scissors, sickle knife, curette and ball 
probe are used for the surgery and handling of these instruments need 
expertise. 
 
 
 
 
 
 
Fig : FESS instruments.  
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Table : Instruments for FESS   
0, 30 & 70 degree nasal endoscopes 
with guard 
 
 
Cold light source & fibre-optic cable 
Suction tips- straight & curved 
Long curved needle/ 26G with 5ml 
syringe 
Anti-fog solution(ultrastop/savlon) 
Freer’s elevator 
Sickle knife 
Ball probe 
Blakesley forceps – straight 45 & 90 
deg 
Ostrum’s reverse cutting forceps 
Kerrison’s punch forceps 
Middle turbinate scissors-straight, 
Right &left 
Curettes & spoons of diff angles 
Video adapter & monitor 
Cautery  
 
SURGICAL TECHNIQUES  
  The basic steps of the anterior to posterior Messerklingler’s 
technique include the following:  
Uncinectomy/Infundibulotomy   
  After medializing the middle turbinate using a Freer’s elevator, the 
uncinate process is identified and its free margin is palpated with a ball 
probe. Incision is given in the shallow groove between the uncinate process 
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and the lacrimal crest, starting superiorly at the level of the insertion of the 
middle turbinate to just above the inferior turbinate. Using Blakesley 
forceps the uncinate process is grasped and removed with a twisting 
motion.  
Middle Meatal Antrostomy  
  After uncinectomy the natural ostium of the maxillary sinus can be 
approached. The ostium lies at the junction of the anterior and inferior walls 
of the ethmoidal bulla. If the ostium is incompletely seen, then it is widened 
with a curette. Posterior fontanelle is examined for any accessory ostium. If 
present, the natural and the accessory ostia are connected using a 
backbiting forceps. Otherwise, a scissors is used to cut and widen the 
natural ostium.  
Anterior Ethmoidectomy   
  The anterior wall of the ethmoidal bulla is entered with the tip of a 
straight forceps. The inferior and medial wall is completely removed while 
maintaining the posterior wall intact, the lamina papyracea forms the lateral 
boundary and skull base the superior boundary of dissection. The posterior 
wall is most of the time fused with the ground lamella.  
Posterior ethmoidectomy   
  The posterior ethmoidal cells are entered through the 
postero-infero-medial part of the ground lamella. The septae of the 
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posterior ethmoidal cells are removed carefully. The boundaries of 
dissection are posteriorly the anterior sphenoid wall, laterally the lamina 
papyracea, superiorly the skull base and the superior turbinate medially.  
Sphenoidotomy   
  After posterior ethmoidectomy, the sphenoid sinus is entered 
postero-inferomedially using a suction tip/forceps. The anterior wall of the 
sphenoid sinus can be ossified in some making it difficult to enter. Up to 
5% of the sphenoid sinuses may not be pneumatized. After entering the 
sphenoid sinus the bony anterior wall is gently removed with the Kerrison’s 
punch upto the level of skull base and medial orbital wall. The intersinus 
septum is later released and the sinus examined.  
Frontal Recess Surgery   
  The frontal sinus opening can be visualized by dissecting upwards 
between the middle turbinate medially and the residual uncinate process 
laterally. The agger nasi cells have to be completely removed. After 
identifying the frontal opening the, cells around the frontal recess are 
removed completely. The mucous membrane is preserved as much as 
possible, otherwise stenosis may occur.  
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    Fig : Uncinectomy.  
(NS-Septum, I-Instrument, EAC-Ethmoid air cell, LNW-Lateral nasal 
wall, UP-Uncinate process, MT-Middle turbinate)  
  Uncinectomy is done for almost all the patients in case of anterior 
FESS. Middle meatal antrostomy is done for maxillary sinusitis folloeing 
uncinectomy. 
   
 
   Fig : Middle meatal antrostomy.  
(FER-Frontoethmoidal recess, EB-Ethmoid bulla, EMO-Enlarged 
maxillary ostium, MA-Maxillary antrum)  
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Fig : Anterior ethmoidectomy, Posterior ethmoidectomy and frontal recess 
clearance being performed. (EC-Ethmoid cell, FS-Frontal sinus)  
Following uncinectomy, for disease in  the anterior ethmoids anterior 
ethmoidectomy is done. If disease involves posterior ethmoids too then 
posterior ethmoidectomy is proceeded.  
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For disease in the sphenoid sinus, sphenoidotomy procedure is done. There 
are various approaches to the sphenoid sinus and one is,the ostium is 1.5 cm 
above the superior border of choana which can be reached after lateralising 
the superior turbinate. Other is through posterior ethmoids. 
 
 
   
   
Fig : Sphenoidotomy. Debri seen within the sphenoid sinus.  
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POST OPERATIVE ENDOSCOPIC PICTURE SHOWING MMA  
 
Post operatively patient is followed for a period of 6 months and post 
operative serial nasal endoscopy cleaning and examination has to be done 
to prevent grusting and synechiae formation. Recurrence can also be 
detected early in case of chronic rhinosinusitis associated with polyps and 
early intervention can be done. 
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POST OPERATIVE MANAGEMENT  
  After the first 24 hrs the nasal pack is removed and the patient may 
be discharged in a day or two. Subsequently the patient is followed up at 
regular intervals, every week for the first one month, every month for the 
next two months, and at the end of sixth months.  
 
 
 
               Table :Complications  
Peroperative  Postoperative  
Hemorrhage  
Entry into the orbit 
CSF leak 
Blindness  
Diplopia 
Injury to ICA 
Intacerebral bleed 
Bleeding 
Synechiae formation 
Subcutaneous emphysema 
Pneumocephalooele 
Meningitis 
Epiphora 
Antrostomy closure 
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MATERIALS AND METHODS  
  30 patients attending ENT Out Patient Department at Government 
Rajaji Hospital,Madurai, with clinical features and investigations 
suggestive of CRS were randomly selected after applying the following 
inclusion and exclusion criteria:  
INCLUSION CRITERIA  
1) All cases of CRS, including allergic and infective, with symptoms for at 
least 12 weeks.  
2) Patients refractory to medical treatment for a minimum of 6 weeks.  
3) Patients above 12 yrs of age. (To avoid the error of grading symptoms 
before and after FESS)  
EXCLUSION CRITERIA  
  1) Patients below 12 years of age.  
  2) Gross DNS.  
  3) Previous nasal surgeries.  
  4) Complications of Chronic sinusitis.  
  5) Growth in the nasal cavity, benign or malignant, except nasal 
polyps.  
Subsequently all the selected candidates were worked up on the following 
pattern: 
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HISTORY  
  • Patients with at least two major, or one major and two minor 
criteria/sinus symptoms were considered. All their symptoms were graded 
preoperatively as mild (1) moderate (2) or severe (3) (grade 0 allotted for 
no symptoms). 
Mild grade - symptoms not disturbing sleep or day-to-day activities;  
Moderate - symptoms disturbing day- to- day activities, with occasional 
absence from work or disturbed sleep;  
Severe - symptoms disturbing day- to- day activities, with absence from 
work and disturbed sleep.  
  • Any history of co-existing bronchial asthma, aspirin sensitivity or 
other systemic ailments like diabetes mellitus or hypertension was looked 
into.  
  • Any history of similar complaints in any of their family members 
was recorded.  
  • Personal habits with regard to smoking and alcohol intake were 
asked for.  
GENERAL EXAMINATION  
  • Vital parameters were recorded.  
  •Systemic examination of the central nervous system, cardiovascular 
system, respiratory system and per abdominal examination were carried 
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out.  
ENT EXAMINATION  
NOSE  
  • External nasal profile: for presence of any nasal deformity or 
inflammation.  
  • Sinus tenderness.  
  • Septum: for any DNS.  
  • Airway: to assess the degree of nasal obstruction, with spatula test.  
  • Inferior turbinate: for hypertrophy, & condition of its mucosa.  
  • Nasal Mucosa: whether pale/ boggy/congested/normal.  
  • Meatii: For any mucopurulent or mucous discharge/polyps.  
  • Posterior rhinoscopy: to assess the posterior extent of the nasal 
polyps when present.  
ORAL CAVITY & OROPHARYNX  
  • Buccal mucosa, tongue and dentition examination.  
  • Anterior pillars and tonsil examination.  
  • Posterior pharyngeal wall examined for evidence of postnasal drip 
or chronic granular changes.  
  • Indirect Laryngoscopic examination done to detect the presence of 
any pathology of the base of tongue, vallecula, epiglottis, arytenoids, 
pyriform fossa or glottis.  
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EAR  
  • Post auricular-area and pinna examined for any operative scar or 
mastoid tenderness.  
  • External auditory canal examined for the presence of any  
  wax/debris/discharge.  
  • Tympanic membrane examined and a note made of its motility, 
integrity, color and luster.  
INVESTIGATIONS  
  1) Routine hematological and biochemical examinations were 
carried out.  
  (Hb%, TLC, DLC, BT, CT. Urine-routine and microscopy. Blood 
sugar- fasting and postprandial, BUN, Serum creatinine, when patient 
above 40 years or with history of DM or HTN.)  
  2) Chest X-Ray and ECG done when patient above 40 years of age, 
or with history of HTN or bronchial asthma: to assess the general condition 
of the patient, and for fitness for surgery.  
  3) X-Ray PNS-Water’s view to assess the condition of the septum, 
inferior turbinates and air-fluid levels, haziness or opacification of the 
sinuses.  
  4) Diagnostic Nasoendoscopy under local anesthesia to record the 
condition of nasal mucosa, septum, & inferior turbinates. To assess the 
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condition of the nasopharynx and eustachian tube opening, to look for the 
presence of mucopus or polyp in the middle meatus/sphenoethmoidal 
recess/nasopharynx. Also, any co-existing anatomical variations of the 
lateral wall of the nose were noted.  
  5) NCCT PNS to assess the extent of disease, condition of OMU, 
degree of opacification of sinuses, bony erosion and roof of the ethmoids 
among others. This was considered as the surgical road map.  
  Once the diagnosis and extent of the disease was established, the 
patients were taken up for FESS, after a pre anesthetic evaluation. The 
surgery was done either under local or general anesthesia, depending on the 
following factors:  
  1) Extent of disease,  
  2) General condition of the patient, and  
  3) Patient’s choice for the type of anesthesia.  
  The surgical procedures were carried out by two senior surgeons, in 
operation theater under strict aseptic precautions (fig19), using the 
endoscopes and the entire set of instruments as mentioned in table 4 .The 
surgical procedures were performed along the guidelines described by 
Messerklinger and Stammberger. The various procedures performed were 
uncinectomy, middle turbinate reduction, MMA, anterior ethmoidectomy, 
posterior ethmoidectomy, sphenoidotomy and frontal recess clearance. The 
 
 
66 
 
various surgical procedures performed depended upon the laterality and the 
extent of the disease. At the end of the surgery, haemostasis was achieved 
and the nose packed with Merocel nasal pack only when the surgery was 
limited to the ground lamella. When the surgery extended beyond the 
ground lamella the nose was packed with medicated ribbon gauze (BIPP or 
Soframycin with betadine) in addition to the Merocel nasal pack.  
  Post-operatively patients were started on appropriate antibiotics (e.g. 
Ampicillin), NSAIDS, oral decongestants and antacids. Nasal packs were 
removed 24 to 48 hours after the surgery depending on the extent of 
surgery. Local decongestants and alkaline nasal douching (common salt-50 
gm, sodium bicarbonate-25 gm and sodium biborate-25 gm in 250 ml of 
sterile water) was started. The patients on the second post operative day or 
third post operative day were discharged with above medications for an 
additional 5 days and asked to come back for review at the end of one week.  
  During the postoperative follow-up, the symptoms were assessed 
using the following grades: much better (+2), better (+1), no change (0), 
worse (-1) and much worse (-2). Nasoendoscopic suction toilet was also 
performed during which the healing of the cavities (fig20) and patency of 
the ostia were monitored. Recurrence of the disease, and presence of crusts, 
synechiae and mucopus were also observed.  
  Grading of symptoms, and nasoendoscopic suction toilet was done at 
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the end of second week, third week, fourth week, second month, third 
month and at the end of six months. From second week onwards, local intra 
nasal steroid sprays were started (Fluticasone / mometasone / 
beclamethasone), especially in patients with extensive polyposis or with 
allergic etiology, and continued for three months. Alkaline nasal douching 
was continued for the initial two to four weeks depending upon the amount 
of crusting seen during the follow-up nasoendoscopic examination. Oral 
steroids (prednisolone) were started preoperatively only for extensive 
polyposis, to reduce their bulk, and postoperatively for recurrences of the 
disease. All the above results were tabulated and the symptoms before and 
after FESS compared statistically using Chi-Square test.  
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      Fig : FESS in progress. 
   
  Fig : Endoscopic picture of post operative healed cavity.   
30 patients with chronic rhinosinusitis are evaluated pre operatively with 
endoscopy and NCCT PNS and subjected to FESS. Later followed up for a 
period of 6 months and observations and results are sorted. 
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OBSERVATIONS AND RESULTS 
30 patients were evaluated in the study in the above said methodology. All 
the patients were refractory to medical management. The observations and 
results of the study are as follows. 
 
19 patients were males (63.33%) and 11 patients were females(36.66%) in 
the study 
 
SEX NO 
MALE 19 
FEMALE 11 
 
 
SEX DISTRIBUTION
MALE
FEMALE
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The average age of the patients in the study was 37 years and the range was 
between 20 to 60 years. Patients less than 12 years are excluded from the 
study. 
 
 
 
 
AGE DISTRIBUTION 
AGE GROUP NO 
21-30 9 
31-40 10 
41-50 7 
51-60 4 
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The duration of symtoms were ranging from 8 months to 20 years and the 
average duration of the patients was 4 years and 4 months. Bilateral disease 
were observed in 28 patients and 2 patients had unilateral disease one in the 
right and other in the left.       
 
 
DURATION OF SYMPTOMS 
DURATION NO OF 
PATIENTS 
3months-1year 5 
1-5 years 15 
6-10 years 8 
11-15 years 1 
16-20 years 1 
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All the patients in the study were given extensive medical treatment before 
subjecting them to surgery. It included anibiotics, local and systemic 
decongestants and steroids (topical and intra-nasal). 
The most common symptom was nasal obstruction- (86.66%, N = 26) from 
the major criteria followed by headache- (80%, N= 24) from the minor 
criteria. Other symptoms were anosmia- (76.66%, N = 23), facial pain/ 
pressure- (73.33%, N = 22), post nasal drip- (70%, N = 21), purulent nasal 
discharge- (43.33%, N=13), ear fullness- (30%, N = 9), halitosis- (26.66%, 
N = 8), cough- (10%, N = 3) and earache- (6.66%, N = 2). 
PRE OPERATIVE SYMPTOM PROFILE – MAJOR CRITERIA 
 
 
MAJOR 
CRITERIA 
NO 
SYMPTOM 
(0) 
MILD 
(1) 
MODERATE 
(2) 
SEVERE 
(3) 
PERCENTAGE 
NASAL 
OBSTRUCTION 
 
8 
 
1 
 
5 
 
16 
 
73.33% 
FACIAL PAIN/ 
PRESSURE 
 
4 
 
3 
 
3 
 
20 
 
 86.66% 
POST-NASAL 
DRIP 
 
9 
 
4 
 
7 
 
10 
 
70% 
ANOSMIA  
7 
 
4 
 
12 
 
7 
 
76.66% 
NASAL 
DISCHARGE 
 
17 
 
3 
 
3 
 
7 
 
43.33% 
FEVER 
(ACUTE) 
 
30 
 
0 
 
0 
 
0 
 
0 
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PRE OPERATIVE SYMPTOM PROFILE – MINOR CRITERIA 
 
 
Most of the patients on anaverage had 3 symptoms from major criteria and 
2 symptoms from minor criteria. The scoring was done in all the patients 
individually for each and evry symptom preoperatively which was 
compared later for evaluating the effect of FESS. 
 
 
 
 
 
MINOR 
CRITERIA 
NO 
SYMPTOM 
(0) 
MILD 
(1) 
MODERATE 
(2) 
SEVERE 
(3) 
PERCENTAGE 
HEADACHE 6 2 4 18 80% 
HALITOSIS 22 4 2 2 26.66% 
DENTAL 
PAIN 
27 2 0 1 10% 
COUGH 27 2 0 1 10% 
EAR ACHE 28 1 0 1 6.66% 
EAR 
FULLNESS 
21 5 2 2 30% 
FEVER 
(NON-ACUTE) 
30 0 0 0 0 
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ANTERIOR RHINOSCOPY FINDINGS 
 
 
 
 
 
 
 
Clinical examination of the patients were done and the anterior rhinoscopy 
findings are listed. Posterior rhinoscopy was also done which revealed 
polyps extending to the choanae in 5 patients with polyps. 
 
0
10
20
PRESENT ABSENT
POLYPS
MUCOPUS
STRUCTURES NO OF PATIENTS PERCENTAGE 
MILD DNS 4 13.33% 
INFERIOR TURBINATE 
HYPERTROPHY 
6 20% 
PALE BOGGY MUCOSA 12 40% 
CONGESTED MUCOSA 1 3.3% 
POLYPS 17 56.66% 
MUCOPUS 10 33.33% 
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X-ray PNS was done in all patients which showed mild DNS in 5 patients 
and septum in the center in 25 patients. Inferior turbinate hypertrophy  in 4 
patients, air fluid level in 2 cases.( B/L-maxillary sinus-1 and Rt frontal 
sinus – 1). 
 
X RAY FINDINGS OF PNS 
 
                              RIGHT                                     LEFT 
  
Ethmoid sinus was hazy in 6 cases and opacified in 3 cases. Sphenoid sinus 
was hazy in 6 cases. 
 
 
 
Diagnostic Nasal Endoscopy was done which revealed the following 
findings. 
 
 
 
SINUSES NORMAL HAZINESS OPACIFIED NORMAL HAZINESS OPACIFIED 
MAXILLARY 
SINUS 
9 13 8 6 14 10 
FRONTAL 
SINUS 
15 10 5 14 10 6 
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     PREOPERATIVE DIAGNOSTIC NASAL ENDOSCOPIC FINDINGS 
 
 
Most of the patients had polyps as their finding in diagnostic nasal 
endoscopy. 12 patients had mucopus and 6 patients had mild  DNS for 
which correction was not necessary. 
 
 
 
 
  
0
5
10
15
20
25
POLYPS
MUCOPUS
PMT
BULBOUS MT
ACCESSORY OSTIA
STRUCTURES NO OF PATIENTS PERCENTAGE 
MILD DNS 6 20% 
POLYPS 21 70% 
MUCOPUS 12 40% 
PARADOXICAL MIDDLE 
TURBINATE 
2 3.33% 
BULBOUS MIDDLE 
TURBINATE 
1 6.66% 
ACCESSORY OSTIA 1 3.33% 
 
 
77 
 
 
Non Contrast Computed Tomography of  Nose and PNS was done in all 
patients with coronal cuts. All CT scans were evaluated by both 
Otolaryngologist and Radiologist. Air fluid level was noted in maxillary 
sinus in 2 cases, in frontal sinus in 1 case bilaterally and  in sphenoid sinus 
in 1 case unilaterally. 
 
NCCT OF THE PNS  
          RIGHT                   LEFT 
SINUSES NORMAL PARTIALLY 
OPACIFIED 
COMPLETELY 
OPACIFIED 
NORMAL PARTIALLY 
OPACIFIED 
COMPLETELY 
OPACIFIED 
ANTERIOR 
ETHMOIDS 
4 14 12 5 10 15 
POSTERIOR 
ETHMOIDS 
5 13 12 6 12 12 
MAXILLARY 
SINUS 
8 11 9 6 11 11 
FRONTAL 
SINUS 
14 9 6 13 9 7 
SPHENOID 
SINUS 
18 4 7 19 4 7 
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OsteoMeatal Unit was found to be blocked in 26 patients in the study. This 
was a key finding which proves the pathophysiology involved in the 
disease. 
0
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After the evaluation and ivestigations work up all the patients in the study 
were subjected to FESS. 15 patients underwent the procedure under local 
anesthesia(50%) and the other 15 patients under general anesthesia(50%). 
Uncinectomy was done in majority of the patients(N = 29, 96.6%), anterior 
ethmoidectomy in 27 patients(90%), middle meatal antrostomy (N = 24 on 
right, N = 25 on left, 83.33%), posterior ethmoidectomy  (N = 22 on left , 
N = 23 on right 76.66%), sphenoidotomy ( N=10, 33.33%), frontal recess 
surgery (N = 7 on right, N = 6 on left 23.33%) and middle turbinate 
reduction (N = 5 on right, N = 4 on left 16.66%). 
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Average duration of the hospital stay was about 3 -5 days.(1 patient was 
admitted for 7 days due to a minor complication. No major complication 
was encountered in all the patients. One patient had a minor problem of 
breach of the lamina papyracea following forceful blowing of the nose on 
the 2nd post operative day after which he developed periorbital emphysema  
which was managed conservatively. Other minor complications such as 
bleeding was seen in 4 patients which was managed conservatively and 
synechiae in 3 patients which were released in post operative period follow 
up. Crusting was seen in majority of the patients in the immediate post 
operative period which was removed in follow up endoscopic nasal 
cleaning. 
During follow up period all the patients were evaluated symptomatically 
and scoring was done for each and every symptom in the order of 1st week, 
2nd week, 3rd week, 4th week, 2nd month, 4th month and 6th month. 
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POST OPERATIVE SYMPTOM PROFILE SCORING-NASAL OBSTRUCTION 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
4 8 15 16 19 23 23 
BETTER 
(+1) 
12 16 10 8 5 0 0 
NO 
CHANGE 
(0) 
10 2 1 1 0 1 0 
WORSE 
(-1) 
0 0 0 0 1 1 2 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Post operatively, 88.46 % of patients with nasal obstruction as a symptom 
showed marked improvement. This was the most common symptom which 
was observed in the study. 
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POST OPERATIVE SYMPTOM PROFILE SCORING- FACIAL PAIN/PRESSURE 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
1 5 11 15 17 18 19 
BETTER 
(+1) 
13 16 10 5 3 2 0 
NO 
CHANGE 
(0) 
8 1 1 1 1 1 2 
WORSE 
(-1) 
0 0 0 0 0 0 0 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients 22 had symptom of facial pain, a major criteria and the 
symptom was scored post operatively 1st week, 2nd week, 3rd week, 4th 
week, 2nd month, 4th month and 6th month. 
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    POST OPERATIVE SYMPTOM PROFILE SCORING- POST NASAL DRIP 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
1 4 10 12 12 18 17 
BETTER 
(+1) 
9 14 11 8 6 1 1 
NO 
CHANGE 
(0) 
11 3 0 0 0 0 0 
WORSE 
(-1) 
0 0 0 0 1 1 2 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients, 21 had symptom of post nasal drip. The symptom 
scoring was done post operatively for a period of 6 months which showed a 
success rate of 86.95%. 
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        POST OPERATIVE SYMPTOM PROFILE SCORING - ANOSMIA 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
0 3 7 10 16 18 20 
BETTER 
(+1) 
10 15 14 10 4 2 0 
NO 
CHANGE 
(0) 
13 5 1 1 1 1 1 
WORSE 
(-1) 
0 0 1 1 1 1 1 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients, 23 had symptom of anosmia which was evaluated in a 
subjective way. Post operative follow up was done and scoring was done 
for 6 months which showed success percentage of 86.95%. 
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  POST OPERATIVE SYMPTOM PROFILE SCORING – NASAL DISCHARGE 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
0 1 4 5 7 9 10 
BETTER 
(+1) 
9 11 8 6 4 1 0 
NO 
CHANGE 
(0) 
4 1 1 1 0 0 0 
WORSE 
(-1) 
0 0 0 0 1 2 2 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients 11 had symptom of nasal discharge. Post operatively 
scoring was done for 6 months regularly which showed success percentage 
of 76.92% which was the least. 
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         POST OPERATIVE SYMPTOM PROFILE SCORING-HEADACHE 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
1 6 13 14 17 21 21 
BETTER 
(+1) 
18 16 11 9 3 0 0 
NO 
CHANGE 
(0) 
5 2 0 0 2 1 1 
WORSE 
(-1) 
0 0 0 0 1 1 1 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients, 24 had symptom of headache which was the second 
most common symptom. Scoring was done for 6 months regularly in the 
post operative period which showed success rate of 87.50%. 
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        POST OPERATIVE SYMPTOM PROFILE SCORING - HALITOSIS 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
4 5 6 6 7 7 8 
BETTER 
(+1) 
2 1 2 2 1 1 0 
NO 
CHANGE 
(0) 
2 2 0 0 0 0 0 
WORSE 
(-1) 
0 0 0 0 0 0 0 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients, 8 patients had symptom of halitosis and post operative 
scoring was done regularly for 6 months of which all 8 patients felt better 
after 6 months which was 100% success rate. 
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      POST OPERATIVE SYMPTOM PROFILE SCORING – DENTAL PAIN 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
2 2 3 3 3 3 3 
BETTER 
(+1) 
1 1 0 0 0 0 0 
NO 
CHANGE 
(0) 
0 0 0 0 0 0 0 
WORSE 
(-1) 
0 0 0 0 0 0 0 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients, 3 patients had symptom of dental pain. Post operative 
scoring was done which showed all 3 patients felt much better after 6 
months of follow up period. 
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            POST OPERATIVE SYMPTOM PROFILE SCORING - COUGH 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
2 2 1 2 2 2 2 
BETTER 
(+1) 
1 1 2 1 1 1 1 
NO 
CHANGE 
(0) 
0 0 0 0 0 0 0 
WORSE 
(-1) 
0 0 0 0 0 0 0 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients, 3 patients had symptom of cough. Post operative 
scoring was done which showed all 2 patients felt much better and 1 felt 
better after 6 months of follow up period. 
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  POST OPERATIVE SYMPTOM PROFILE SCORING - EARACHE 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
1 1 1 1 2 2 2 
BETTER 
(+1) 
1 1 1 1 0 0 0 
NO 
CHANGE 
(0) 
0 0 0 0 0 0 0 
WORSE 
(-1) 
0 0 0 0 0 0 0 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
 
Among 30 patients, 2 patients had symptom of earache. Post operative 
scoring was done which showed all 2 patients felt much better after 6 
months of follow up period. 
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POST OPERATIVE SYMPTOM PROFILE SCORING – EAR FULLNESS 
 1ST 
WEEK 
2ND 
WEEK 
3RD 
WEEK 
4TH 
WEEK 
2ND 
MONTH 
4TH 
MONTH 
6TH 
MONTH 
MUCH 
BETTER 
(+2) 
6 6 6 5 6 7 7 
BETTER 
(+1) 
2 2 3 4 3 2 2 
NO 
CHANGE 
(0) 
1 1 0 0 0 0 0 
WORSE 
(-1) 
0 0 0 0 0 0 0 
MUCH 
WORSE 
(-2) 
0 0 0 0 0 0 0 
 
Among 30 patients, 9 patients had symptom of ear fullness. Post operative 
scoring was done which showed all 7 patients felt much better and 2 felt 
better after 6 months of follow up period. 
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6
7
EAR FULLNESS
MUCH BETTER(2)
BETTER(1)
NO CHANGE(0)
WORSE(-1)
MUCH WORSE(-2)
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POST OPERATIVE SYMPTOM PROFILE AT THE END OF SIX 
MONTHS FOLLOW UP 
 
 
 
SYMPTOMS MUCH 
WORSE 
(-2) 
WORSE 
(-1) 
NO 
CHANGE 
(0) 
BETTER 
(1) 
MUCH 
BETTER 
(2) 
PERCENTAGE P 
VALUE 
NASAL 
OBSTRUCTION 
0 2 0 0 23 88.46% <0.001 
FACIAL PAIN 0 0 2 0 19 86.36% <0.001 
POST NASAL 
DRIP 
0 2 0 1 17 85.71% <0.001 
ANOSMIA 0 1 1 0 20 86.95% <0.001 
NASAL 
DISCHARGE 
0 2 0 0 10 76.92% <0.001 
HEADACHE 0 1 1 0 21 87.50% <0.001 
DENTAL PAIN 0 0 0 0 3 100% <0.001 
COUGH 0 0 0 1 2 100% <0.001 
EAR ACHE 0 0 0 0 2 100% <0.001 
EAR 
FULLNESS 
0 0 0 2 7 100% <0.001 
HALITOSIS 0 0 0 0 8 100% <0.001 
 
 
 
 
Post operatively all the symptoms were individually scored in 1st week, 2nd 
week, 3rd week, 4th week, 2nd month, 4th month and 6th month and were 
compared with the pre operative scores and success rate was calculated 
with chi- square test. 
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OVERALL PATIENT SATISFACTION POST OPERATIVELY 
AFTER SIX MONTHS FOLLOW UP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Post operatively the patient satisfaction over-all based on the symptom 
profile was high. 86.66%  of the patients in the study felt Much Better (p 
value <0.001) after the treatment with FESS.  One patient - 3.33% had no 
PERCENTAGE OF PATIENTS
MUCH BETTER
NO CHANGE
WORSE
SATISFACTION PERCENTGE OF PATIENTS 
MUCH BETTER 86.66% 
BETTER 0 
NO CHANGE 3.33% 
WORSE 6.66% 
MUCH WORSE 0 
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change and two patients – 6.66% felt worse after surgery. One patient went 
out of the follow up period and was recorded as a failure one. The scoring 
category of  no change, worse and much worse were considered to be 
failures in the post operative period. Thus the observations and results 
showed that FESS was the best and effective treatment modality for chronic 
rhinosinusitis alleviating most of the symptoms improving physical quality 
of life. 
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DISCUSSION  
  Chronic Rhinosinusitis is one of the most common diseases in many 
parts of the world including India. The prevalence of CRS is on the rise 
posing a serious health care problem in the society and hence a proper 
evaluation of the disease and its treatment modality by testing its 
effectiveness is very much needed. 
The most important part of evaluation remains history. This includes 
nasal obstruction-(N=26, 86.66 %), which was the commonest symptom in 
our patients, followed by headache-(N=24, 80 %), anosmia-(N=23, 76.66 
%), facial pressure/pain-(N=22, 73.33 %), post-nasal drip-(N=21, 70  %), 
& purulent nasal discharge (N= 13, 43.33 %). Fever was not one of the 
presenting complaint in any of the patients. Symptoms of minor criteria  
were headache (N=24, 80%), halitosis (N=8,26.66 %), dental pain 
(N=3,10%), cough (N=3,10 %), earache (N=2,6.6 %) and ear fullness 
(N=9,30%). Post operatively, 88.46 % of patients with nasal obstruction as 
a symptom showed marked improvement.  87.50 % of patients with 
headache, 86.95 % of pts with anosmia, 86.36 % pts with facial pain / 
pressure, 85.71 % pts with post-nasal drip and 76.92 % pts with nasal 
discharge as a major symptom showed marked improvement post- FESS 
after 6 months follow up. 100 % improvement was observed after FESS 
with all the minor symptoms. The symptom that responded the least among 
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the major symptoms was purulent nasal discharge and the best one was 
nasal obstruction. The findings of our study were consistent with many 
other similar series of study. The percentage of patients in the study who 
showed marked improvement after FESS and good symptom relief and 
satisfaction is 86.66% and they required no medical treatment after 6 month 
follow up. 
  Brain L Mathew et al (1991) documented nasal obstruction as the 
commonest symptom (n=146,96%) followed by postnasal drip 
(n=143,92%), & facial pain/headache (n=139-90%). Overall, 140 patients 
(91%) believed that surgery was beneficial. Patients with facial pain 
preoperatively showed greatest improvement.  
   Jakobsen J and Svendstrup F (2000) conducted a prospective study 
on 237 consecutive patients suffering from chronic sinusitis and /or nasal 
polyposis.Nasal obstruction was the most frequent symptom (61%) 
followed by purulent nasal discharge, anosmia, frontal pain, headache and 
maxillary pain. Duration of symptoms averaged 9.3 years. At the end of 1 
year follow up, 45% were totally satisfied with the results and were 
symptom-free, and 44% more definitely feeling better.  
    
  In the pre operative work up of our study, 5 cases were found to have 
mild DNS and 4 inferior turbinate hypertrophy, all requiring no surgical 
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intervention for the same. Three patients had air fluid level (2 in both 
maxillary sinuses, and 1 in frontal sinus) on NCCT nose and PNS. The 
X-Ray and CT findings are given in Fig 25 & table 9 and Fig 27 & table 11. 
24 patients (80%) had their OMU blocked bilaterally, strongly establishing 
the Messerklinger’s concept of OMU block in pathophysiology of CRS.21 
patients (70 %) revealed nasal polyps on daigostic nasoendoscopy.  
  15 cases underwent the procedure under local anesthesia and another 
15 underwent the procedure under general anesthesia. Certain factors like 
age,sex, disease severity, patient’s will and general condition determined 
the type of anesthesia with no significant difference in the period of 
hospital stay. However, patient was comfortable in general anesthesia. 
Majority of the patients underwent uncinectomy (96.6%, N=29), followed 
by anterior Ethmoidectomy (90%, N=27). The other procedures done were 
middle meatal antrostomy (83.33%, N=24 on right, N=25 on left), posterior 
ethmoidectomy (76.66%, N=22 on left, N=23 on right), sphenoidotomy 
(33.33%, N=10), frontal recess surgery (23.33%, N=7 on right, N=6 on 
left) and middle turbinate reduction (16.66%, N=5 on right, N=4 on left). 
Average duration of hospitalization was 3 to 4 days. (One patient had to be 
admitted for 6 days because of a minor complication).  
FESS is an effective and safe procedure when performed by 
surgeons experienced in the technique. In inexperienced hands, the major 
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complications that may occur after FESS are CSF leak, intracerebral 
hemorrhage, diplopia, blindness,meningitis,severe nasal hemorrhage and 
intracranial penetration.In our study, there were no major complications 
recorded. The most common minor complication was post-operative 
bleeding (N=4), which was managed successfully with nasal packing. 
Synechiae (N=3) were the next common complication, which were 
released during the postoperative follow-up. The breach of lamina 
papyracea was the only minor complication that occurred in one patient and 
this patient subsequently developed periorbital emphysema, after he blew 
his nose inadvertently on the second post-operative day. The patient was 
treated conservatively and he subsequently improved without any sequelae. 
Our complication rates are the same as reported by other authors. Average 
postoperative healing time was 4 to 8 weeks. A few (N=5, 16.66 %) of them 
required 12 weeks, during which time regular nasal toilet was done to 
remove crusts/debris (fig 29).  
  Schaffer SD et al, in his study noticed minor complications in 14 
patients, the most common complication being synechiae between middle 
turbinate and septum in 6 patients, resulting in revision surgery in four 
patients 10. In the series conducted by Howard L. Levine (1990) 8.3% 
developed minor complications and 0.7% developed major complications 
11. Hemorrhage occurred postoperatively in 2 patients (1.5%) in the study 
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done by Brain L Mathew et al (1991) 12. Nasser A Fageeh et al recorded 
minor complications like mild to moderate nasal bleeding, synechiae & 
facial swelling. One major complication in the form of internal carotid 
artery rupture was noted.. Jakobsen J and Svendstrup F  
  (2000) came across no serious complications 16, while RothY et al 
(1995) observed 17% complications (all minor) 19.Terris MH and 
Davidson TM (1999) in their series recorded major complications in 1.6% 
of the patients 20.  
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CONCLUSION  
  • FESS is the best available treatment modality for Chronic 
Rhinosinusitis. Symptomatic relief was successfully established in 
86.66%of patients 
 • The most common symptoms were Nasal obstruction, facial 
pressure/pain, anosmia, post nasal drip in major criteria and headache from 
minor criteria. 
   • The preoperative Non Contrast Computed Tomography of nose and 
paranasal sinuses revealed the disease/infection predominantly involved 
the anterior ethmoids and infundibulum and of rhinogenic in origin 
followed by the posterior ethmoids and maxillary sinus.   
 • The common procedures that were done bilaterally in most of the 
cases were uncinectomy, MMA and anterior ethmoidectomy.  
• In the hands of an experienced surgeon the post operative 
complications of FESS are minimal. 
  • The symptoms that responded well after FESS were nasal 
obstruction, headache and all the other minor symptoms. 
 • Post FESS after the period of 6 months follow up no medical 
treatment was required by most of the patients.   
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PROFORMA 
 
Name: 
Age: 
Adress: 
Case Number: 
D.O.A: 
D.O.S: 
D.O.D: 
History: 
Major Criteria Score Duration 
Facial Pressure/Pain 0 1 2 3  
Nasal Obstruction 0 1 2 3  
Post Nasal Discharge 
 
0 1 2 3  
Anosmia 0 1 2 3  
Nasal discharge 0 1 2 3  
Fever (acute) 0 1 2 3  
Minor Criteria Score Duration 
Headache 0 1 2 3  
Fever (non acute) 0 1 2 3  
Halitosis 0 1 2 3  
Dental pain 0 1 2 3  
Cough 0 1 2 3  
Ear ache 0 1 2 3  
Ear fullness 0 1 2 3  
Score 0  No Symptoms 
Score 1 Occasional symptoms not disturbing sleep/day to day activities/work 
Score 2 Symptoms disturbing day do day activities,with occasional absence from 
work / disturbed sleep 
Score 3 Symptoms disturbing day to day activities,with absence from work and 
disturbed sleep more often than not 
 
 Encircle the number according to the severity against the symptom and mention its duration 
 
Past History: 
 
Family History: 
 
Personal History: 
 
Drug History: 
 
 
 
 
Examination of the Nose: 
External Pyramid 
 
 
Anterior Rhinoscopy  
 Septum 
 
 
Turbinate 
 
 
Mucosa 
 
 
Discharge 
 
 
Airway 
 
 
Others (eg: polyp) 
 
 
Posterior Rhinoscopy  
Sinus Examination/Tenderness  
 
Examination of the Ear: 
 
 
 
 
 
 
 
Examination of the Throat: 
 
 
 
 
 
Examination of the Head and Neck: 
 
  
 
 
X- Rays of the Nose and PNS: 
 
 
Haziness of the sinuses 
 
 
Opacification of the sinuses 
 
 
Thickening of mucosa 
 
 
Air fluid level 
 
 
Turbinates 
 
 
Septum 
 
 
Others 
 
 
 
 
Diagnostic Nasal Endoscopy: 
 
Passes 
 
            Right             Left 
First Pass 
 
  
Second Pass 
 
 
  
Third Pass 
 
 
  
 
NCCT of the Nose and PNS 
Sinuses   
 Anterior Ethmoid 
 
  
Posterior Ethmoid 
 
  
Maxillary Sinus 
 
  
Frontal sinus 
 
  
Sphenoid Sinus 
 
  
Osteomeatal Unit 
 
  
Others 
 
  
 
No opacification,partialopacification,completeopacification 
OMU not blocked,OMU blocked 
 
Surgery Details: LA/GA 
 
Procedure  
 
           Right                   Left 
Uncinectomy 
 
  
Reduction of MT 
 
  
Anterior Ethmoidectomy 
 
  
Posterior Ethmoidectomy 
 
  
Sphenoidotomy 
 
  
Frontal Recess Surgery 
 
  
 
Surgery not performed.surgery performed 
 
Follow Up: 
 
Week/Month Symptomatology Nasoendoscopy 
 
      Right 
 
       Left 
Fisrt week 
 
   
Second Week 
 
   
Third Week 
 
   
Fourth Week 
 
   
Second Month 
 
   
Third Month 
 
   
Sixth Month 
 
   
-2:Much worse, -1: Worse,0: No change,+1: Better,+2: Much Better 
 
 
 
 
 
 
 
 
Overall Assessment/ satisfaction: 
 
-2 
 
All symptoms worsened 
-1 
 
Few symptoms worsened,rest unchanged 
0 
 
No change in any of the symptoms 
 
+1 
 
Few symptoms better,rest unchanged 
 
+2 
 
All symptoms better 
Tick against the relevant box 
LIST OF ABBREVIATIONS USED  
 (in alphabetical order)  
  
 AN - Aggernasi 
 AR - Allergic rhinitis 
 AP - Anteroposterior 
 A - Artery  
 BL - Basal lamella  
 BLPB - Beta lactamase producing bacillus 
 BIPP - Bismuth iodoform paraffin paste  
 BT - Bleeding time  
 BUN - Blood urea nitrogen 
 Cms - Centimeters  
 CRS - Chronic rhino sinusitis 
 CT - Clotting time  
 CT-scan - Computer tomographic scan  
 C-AMP - Cyclic adenine monophosphate  
 DNS - Deviated nasal septum  
 DM - Diabetes mellitus 
 DLC - Differential leukocyte count 
 ENT - Ear Nose Throat 
 ECG - Electrocardiogram  
 EAC - Ethmoid air cells 
 EB - Ethmoid air cells  
 EC - Ethmoid cells   
 EI - Ethmoid infundibulum   
 e.g. - For Example  
 FR - Frontal recess  
 FS - Frontal sinus   
 FESS - Functional endoscopic sinus surgery  
Gms - Grams  
 Hb % - Haemoglobin percentage 
 HS - Hiatus semilunaris 
 
 HPE - Histopathology 
 HTN - Hypertension  
 IT - Inferior turbinate 
 I - Instrument 
 LNW - Lateral nasal wall 
 MRI - Magnetic resonance imaging  
 MSO - Maxillary sinus ostium 
 MMA - Middle meatalantrostomy 
 MT - Middle turbinate 
 Middle meatus  
 MM - Middle meatus 
 MP - Mucopus 
 NS - Nasal septum  
NT - Nasoturbinals 
 N - Nerve  
 OD - Once daily 
 OMU - Osteomeatal unit  
 PNS - Paranasal sinus 
 Pts - patients 
 Prof - Professor 
 P - Polyp  
 PEC - Posterior ethmoid cell  
 SL - Sinus lateralis 
 SS - Sphenoid sinu 
 SBR - Sphenoid sinu 
 spp - Species  
 TLC - Total differential count  
 TO - Tubal openings  
 BD - Twice daily 
 Uncinate process  
 UP - Uncinate process 
 yearsYrs/yr - Uncinate process 
 
S.NO. NAME AGE SEX I.P. NO DURATION OF SYMPTOMS                                                                           PRE-OP SYMPTOM SCORING
NO
1 Ganesan 44 M 43945 6 months 1
2 Selvi 40 F 49681 2 years 2
3 Ilayaraja 21 M 45661 3 years 2
4 Alagarsamy 25 M 55687 8 months 2
5 Vigneshwaran 30 M 60081 1 year 0
6 Pandi 31 M 67957 3 years 0
7 Parvathi 50 F 66594 7 months 3
8 Kumar 45 M 82790 6 years 3
9 Ayyammal 28 F 87676 3.5 years 3
10 Kasthuri 31 F 90255 2.5 years 3
11 Jemila 26 F 92101 3 years 3
12 Nagaraj 55 M 93263 7 years 3
13 Ramachandran 26 M 3438 4 years 2
14 Kannan 29 M 7325 3 years 3
15 Sangeetha 32 F 9724 2 years 0
16 Kanagavel 48 M 10415 6 months 3
17 Balu 34 M 10965 4.5 years 3
18 Raman 55 M 12926 8 years 3
19 Amudha 29 F 13579 1.5 years 3
20 Malarvizhi 48 F 15876 8 years 3
21 Muthiah 60 M 18137 15 years 3
22 Sathish kumar 36 M 21493 6 years 3
23 Ravichandran 37 M 23278 6 years 3
24 Muniyammal 30 F 23304 2 years 1
25 Murugan 32 M 28942 8 months 3
26 Deepa 33 F 33805 4 years 3
27 Venkatesh 36 M 34823 7 years 0
28 Senthurapandiyan 43 M 40529 3.5 years 3
29 Marimuthu 52 M 33842 12 years 3
30 Narayanan 44 M 44880 7 years 3
                                                                          PRE-OP SYMPTOM SCORING
FP PD ANOSMIA ND HEADACHE HALITOSIS DP COUGH EARACHE EAR FULLNESS
3 3 0 0 3 0 0 0 0 0
0 0 1 2 3 0 0 0 0 0
3 0 2 3 3 0 0 1 0 0
3 1 0 0 3 0 0 0 0 0
3 2 1 0 3 0 0 0 0 0
3 3 2 0 3 0 0 0 0 0
3 0 0 0 3 0 0 0 0 0
3 0 3 2 0 1 0 0 1 1
0 3 2 3 3 0 0 0 0 1
3 1 2 0 3 0 0 1 0 0
3 2 0 0 3 0 0 0 0 0
3 0 3 1 0 2 0 0 0 0
0 3 2 3 2 0 3 0 1 1
2 1 2 0 3 0 0 0 0 0
3 2 2 0 3 0 0 0 0 0
3 0 0 0 3 0 0 0 0 0
0 3 2 0 2 1 0 3 0 0
2 0 3 3 0 2 0 0 0 2
3 2 0 0 3 0 1 0 0 0
3 0 3 0 1 0 0 0 0 1
0 2 2 3 0 3 0 0 0 3
2 3 1 1 2 1 0 0 0 0
0 3 2 0 2 0 0 0 0 1
3 3 2 0 3 0 0 0 0 0
3 3 0 0 3 0 0 0 0 0
3 0 1 1 3 0 0 0 0 0
2 2 2 3 1 1 0 0 0 2
2 3 2 0 3 0 1 0 0 0
0 2 3 3 0 3 0 0 0 3
0 1 3 2 0 0 0 0 0 0
                                         ANTERIOR RHINOSCOPY                               XRAY PNS
DNS ITH PBM CM POLYP MUCOPUS MAXILLARY FRONTAL ETHMOIDS
YES NO NO NO NO NO Normal Normal Hazy
NO NO NO NO NO YES L-opacified Normal Normal
NO YES YES NO YES YES L-hazy Normal Normal
NO NO NO NO NO NO Normal Normal Hazy
YES NO NO YES NO NO Normal Normal opacified
NO NO YES NO YES YES b/l hazy b/l hazy Normal
NO YES NO NO NO NO Normal Normal Hazy
NO NO YES NO YES YES b/l hazy b/l hazy Normal
NO NO YES NO YES YES b/l hazy Normal Normal
NO NO NO NO NO NO b/l hazy b/l hazy Normal
NO YES YES NO NO NO b/l hazy Normal Normal
NO NO NO NO YES NO b/l opacified b/l opacified Normal
NO NO YES NO YES YES b/l hazy b/l hazy Normal
NO NO NO NO NO NO b/l hazy Normal Normal
YES YES YES NO YES NO b/l hazy b/l hazy Normal
NO NO NO NO NO NO Normal Normal Hazy
NO NO YES NO YES NO b/l opacified b/l opacified Normal
NO NO NO NO YES YES b/l opacified b/l hazy opacified
NO YES YES NO NO NO Normal Normal Hazy
NO NO YES NO YES NO b/l opacified L-opacified Normal
NO NO NO NO YES YES b/l opacified b/l hazy Normal
NO NO YES NO YES NO b/l hazy b/l hazy Normal
NO NO YES NO YES NO b/l hazy Normal Normal
NO NO NO NO NO NO L-opacified Normal Normal
YES NO NO NO NO NO b/l opacified b/l opacified Hazy
NO NO NO NO YES NO b/l hazy Normal Normal
NO NO YES NO YES YES b/l hazy b/l hazy Normal
NO YES NO NO NO NO b/l hazy b/l hazy Normal
NO NO NO NO YES YES b/l opacified b/l opacified opacified
NO NO NO NO YES NO b/l opacified b/l opacified Normal
                                        DIAGNOSTIC NASAL ENDOSCOPY
SPHENOID DNS POLYPS MUCOPUS BULBOUS MT PARADOXICAL MT ACCESSORY OSTIA
Normal YES  -  -  -  -  -
Normal  -  - YES  -  - YES
Normal  - YES YES  -  -  -
Normal  -  -  -  -  -  -
Normal YES  -  -  -  -  - 
Normal  - YES YES  -  -  -
Normal  -  -  -  -  -  -
Hazy  - YES YES  -  -  -
Normal  - YES YES YES  -  -
Normal YES YES  -  -  -  -
Normal  - YES  -  -  -  -
hazy  - YES  -  -  -  -
Normal  - YES YES  - YES  -
Normal  -  -  -  -  -  -
Normal YES YES  -  -  -  -
Normal  -  -  -  -  -  -
Normal  - YES  -  -  -  -
Hazy YES YES YES  -  -  -
Normal  -  -  -  -  -  -
Normal  - YES YES  -  -  -
Hazy  - YES YES  -  -  -
Normal  - YES  -  -  -  -
Normal  - YES  -  -  -  -
Normal  -  -  -  -  -  -
Hazy YES YES  - YES  -  -
Normal  - YES  -  -  -  -
Normal  - YES YES  -  -  -
Normal  - YES  -  -  -  -
Hazy  - YES YES  -  -  -
Normal  - YES YES  -  -  -
                                              NCCT-PNS
MAXILLARY A.E. P.E. FRONTAL SPHENOID
Normal b/l opacified b/l opacified Normal Normal
L-opacified L-opacified Normal Normal Normal
b/l partial b/l partial b/l partial Normal Normal
Normal b/l opacified b/l partial Normal Normal
Normal b/l opacified b/l opacified Normal b/l opacified
b/l partial b/l partial b/l partial b/l partial Normal
Normal b/l opacified b/l opacified Normal Normal
b/l partial b/l partial b/l partial b/l partial b/l opacified
b/l partial R-opacified Normal Normal Normal
b/l partial b/l partial b/l partial b/l partial b/l partial
b/l partial R-opacified Normal Normal Normal
b/l opacified b/l opacified b/l opacified b/l opacified b/l opacified
b/l partial R-opacified R-opacified b/l partial Normal
b/l partial R-opacified b/l partial Normal Normal
b/l partial b/l partial b/l partial b/l partial b/l partial
Normal b/l opacified b/l opacified Normal Normal
b/l opacified b/l partial b/l partial b/l opacified b/l partial
b/l opacified b/l opacified b/l opacified b/l partial b/l opacified
Normal b/l opacified b/l opacified Normal Normal
b/l opacified b/l partial b/l partial L-opacified Normal
b/l opacified b/l partial b/l partial b/l partial b/l opacified
b/l partial R-opacified Normal b/l partial Normal
b/l partial Normal Normal Normal Normal
L-opacified L-opacified b/l opacified Normal Normal
b/l opacified b/l opacified b/l opacified b/l opacified b/l opacified
b/l partial b/l partial b/l partial Normal Normal
b/l opacified b/l opacified b/l opacified b/l opacified b/l partial
b/l partial b/l partial b/l partial b/l partial Normal
b/l opacified b/l opacified b/l opacified b/l opacified b/l opacified
b/l opacified b/l opacified b/l opacified b/l opacified Normal
PROCEDURES
U+MMA+A.ETY+P.ETY
U+MMA+MTR
U+MMA+A.ETY+P.ETY
U+A.ETY+MTR
U+A.ETY+P.ETY+SPHY
U+MMA+A.ETY+P.ETY
U+A.ETY+P.ETY
U+MMA+A.ETY+P.ETY+SPHY
U+MMA+MTR
U+MMA+A.ETY+P.ETY+SPHY
U+MMA+A.ETY+R-MTR
U+MMA+A.ETY+P.ETY+SPHY+FRS
U+MMA+A.ETY+R-P.ETY
U+MMA+A.ETY+P.ETY
U+MMA+A.ETY+P.ETY+SPHY
U+A.ETY+P.ETY
U+MMA+A.ETY+P.ETY+SPHY+FRS
U+MMA+A.ETY+P.ETY+SPHY
U+A.ETY+P.ETY
U+MMA+A.ETY+P.ETY
U+MMA+A.ETY+P.ETY+SPHY+R-FRS
U+MMA+A.ETY
U+MMA
L-MMA+A.ETY+P.ETY
U+MMA+A.ETY+P.ETY+SPHY+FRS+MTR
U+MMA+A.ETY+P.ETY
U+MMA+A.ETY+P.ETY+SPHY+FRS
U+MMA+A.ETY
U+MMA+A.ETY+P.ETY+SPHY+FRS
U+MMA+A.ETY+P.ETY+FRS
S.NO. NAME AGE SEX I.P. NO                                                                                                                   POST OP SYMPTOM SCORING
                          NASAL OBSTRUCTION
1st wk 2nd wk 3rd WK 4th WK
1 Ganesan 44 M 43945 0 1 2 2
2 Selvi 40 F 49681 1 1 2 2
3 Ilayaraja 21 M 45661 0 1 1 2
4 Alagarsamy 25 M 55687 0 1 2 2
5 Vigneshwaran 30 M 60081 0 0 0 0
6 Pandi 31 M 67957 0 0 0 0
7 Parvathi 50 F 66594 2 2 2 2
8 Kumar 45 M 82790 2 2 2 2
9 Ayyammal 28 F 87676 1 1 1 1
10 Kasthuri 31 F 90255 1 2 2 2
11 Jemila 26 F 92101 1 1 1 1
12 Nagaraj 55 M 93263 1 2 2 2
13 Ramachandran 26 M 3438 0 1 2 2
14 Kannan 29 M 7325 0 1 2 2
15 Sangeetha 32 F 9724 0 0 0 0
16 Kanagavel 48 M 10415 1 1 1 1
17 Balu 34 M 10965 0 0 0 0
18 Raman 55 M 12926 1 2 2 2
19 Amudha 29 F 13579 0 1 2 2
20 Malarvizhi 48 F 15876 1 1 1 1
21 Muthiah 60 M 18137 2 2 2 2
22 Sathish kumar 36 M 21493 1 1 1 1
23 Ravichandran 37 M 23278 1 2 2 2
24 Muniyammal 30 F 23304 0 1 2 2
25 Murugan 32 M 28942 0 1 1 1
26 Deepa 33 F 33805 0 0 1 1
27 Venkatesh 36 M 34823 0 0 0 0
28 Senthurapandiyan 43 M 40529 1 1 1 1
29 Marimuthu 52 M 33842 2 2 2 2
30 Narayanan 44 M 44880 1 1 1 1
                                                                                                                  POST OP SYMPTOM SCORING
                          NASAL OBSTRUCTION                                        FACIAL PAIN/PRESSURE                                                               POST NASAL DRIP
2nd Mnth 4th mnth 6th mnth 1st wk 2nd wk 3rd wk 4th wk 2nd mnth 4th mnth 6th mnth 1st wk
2 2 2 1 2 2 2 2 2 2 1
2 2 2 0 0 0 0 0 0 0 0
2 2 2 1 2 2 2 2 2 2 0
2 2 2 1 1 2 2 2 2 2 0
0 0 0 1 2 2 2 2 2 2 0
0 0 0 1 2 2 2 2 2 2 1
2 2 2 1 1 2 2 2 2 2 0
2 2 2 1 1 2 2 2 2 2 0
1 2 2 0 0 0 0 0 0 0 1
2 2 2 0 1 1 2 2 2 2 0
2 2 2 1 1 2 2 2 2 2 0
2 2 2 1 1 1 1 1 2 2 0
2 2 2 0 0 0 0 0 0 0 1
2 2 2 0 1 1 1 2 2 2 0
0 0 0 0 1 2 2 2 2 2 0
1 2 2 2 2 2 2 2 2 2 0
-1 -1 -1 0 0 0 0 0 0 0 1
2 2 2 0 0 0 1 1 1 0 0
2 2 2 1 1 1 1 2 2 2 0
2 2 2 1 1 2 2 2 2 2 0
2 2 2 0 0 0 0 0 0 0 0
1 2 2 0 1 1 0 0 0 0 1
2 2 2 0 0 0 0 0 0 0 1
2 2 2 0 1 1 1 1 1 2 1
1 2 2 0 1 1 1 1 1 2 1
1 0 -1 1 1 1 2 2 2 2 0
0 0 0 1 1 1 2 2 2 2 0
2 2 2 0 1 1 2 2 2 2 2
2 2 2 0 0 0 0 0 0 0 0
1 1 2 0 0 0 0 0 0 0 0
                                                              POST NASAL DRIP                                                                  ANOSMIA
2nd wk 3rd wk 4th wk 2nd mnth 4th mnth 6th mnth 1st wk 2nd wk 3rd wk 4th wk 2nd mnth 4th mnth
1 1 2 2 2 2 0 0 0 0 0 0
0 0 0 0 0 0 0 1 1 2 2 2
0 0 0 0 0 0 0 1 1 1 2 2
0 1 2 2 2 1 0 0 0 0 0 0
1 1 1 1 2 2 0 1 1 2 2 2
1 1 1 1 2 2 0 1 1 1 2 2
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 1 1 1 1 1 2
1 2 2 2 2 2 0 1 1 1 2 2
1 1 1 -1 -1 -1 0 0 1 1 1 2
0 1 1 1 1 -1 0 0 0 0 0 0
0 0 0 0 0 0 1 2 2 2 2 2
2 2 2 2 2 2 0 1 2 2 2 2
0 1 1 1 2 2 1 1 1 2 2 2
1 1 1 1 2 2 0 0 1 1 1 1
0 0 0 0 0 0 0 0 0 0 0 0
2 2 2 2 2 2 1 2 2 2 2 2
0 0 0 0 0 0 1 1 1 1 2 2
1 1 1 1 2 2 0 0 0 0 0 0
0 0 0 0 0 0 1 0 -1 -1 -1 -1
1 2 2 2 2 2 0 1 1 1 1 2
2 2 2 2 2 2 0 1 2 2 2 2
1 2 2 2 2 2 0 1 1 1 2 2
1 1 1 1 2 2 0 0 1 1 2 2
1 2 2 2 2 2 0 0 0 0 0 0
0 0 0 0 0 0 1 1 1 1 1 1
1 1 1 1 2 2 1 2 2 2 2 2
2 2 2 2 2 2 0 0 0 0 0 0
1 2 2 2 2 2 1 1 2 2 2 2
1 2 2 2 2 2 1 1 2 2 2 2
                                                                      NASAL DISCHARGE                                                                                       HEADACHE
6th mnth 1st wk 2nd wk 3rd wk 4th wk 2nd mnth 4th mnth 6th mnth 1st wk 2nd wk 3rd wk 4th wk
0 0 0 0 0 0 0 0 2 2 2 2
2 1 1 1 1 1 2 2 1 2 2 2
2 1 1 1 1 1 1 2 1 1 1 2
0 0 0 0 0 0 0 0 1 2 2 2
2 0 0 0 0 0 0 0 1 1 1 1
2 0 0 0 0 0 0 0 1 1 2 2
0 0 0 0 0 0 0 0 1 1 1 1
2 1 1 1 1 2 2 2 0 0 0 0
2 0 1 1 1 1 -1 -1 1 1 2 2
2 0 0 0 0 0 0 0 1 1 2 2
0 0 0 0 0 0 0 0 1 1 1 1
2 0 1 2 2 2 2 2 0 0 0 0
2 1 1 1 1 2 2 2 1 1 2 2
2 0 0 0 0 0 0 0 0 1 2 2
2 0 0 0 0 0 0 0 1 2 2 2
0 0 0 0 0 0 0 0 0 1 1 1
2 0 0 0 0 0 0 0 1 2 2 2
2 1 1 1 1 1 2 2 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1 1
-1 0 0 0 0 0 0 0 0 0 1 1
2 1 2 2 2 2 2 2 0 0 0 0
2 1 1 1 1 1 2 2 1 1 1 1
2 0 0 0 0 0 0 0 1 1 1 1
2 0 0 0 0 0 0 0 1 2 2 2
0 0 0 0 0 0 0 0 1 1 1 1
2 0 0 0 0 -1 -1 -1 0 1 2 2
2 1 1 1 2 2 2 2 1 1 2 2
0 0 0 0 0 0 0 0 1 1 1 1
2 1 1 2 2 2 2 2 0 0 0 0
2 0 1 2 2 2 2 2 0 0 0 0
                                                                                      HEADACHE                                                                                      HALITOSIS                                                                           DENTAL PAIN
2nd mnth 4th mnth 6th mnth 1st wk 2nd wk 3rd wk 4th wk 2nd mnth 4th mnth 6th mnth 1st wk
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
1 2 2 0 0 0 0 0 0 0 0
0 0 0 2 2 2 2 2 2 2 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
0 2 2 0 0 0 0 0 0 0 0
0 0 0 1 1 2 2 2 2 2 0
2 2 2 0 0 0 0 0 0 0 2
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
1 2 2 0 0 0 0 0 0 0 0
2 2 2 2 2 2 2 2 2 2 0
0 0 0 0 0 1 1 2 2 2 0
0 0 0 0 0 0 0 0 0 0 1
-1 -1 -1 0 0 0 0 0 0 0 0
0 0 0 2 2 2 2 2 2 2 0
2 2 2 0 0 1 1 1 1 2 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 0 0 0 0 0 0 0 0
2 2 2 2 2 2 2 2 2 2 0
1 2 2 0 0 0 0 0 0 0 2
0 0 0 1 2 2 2 2 2 2 0
0 0 0 0 0 0 0 0 0 0 0
                                                                          DENTAL PAIN                                                                                              COUGH
2nd wk 3rd wk 4th wk 2nd mnth 4th mnth 6th mnth 1st wk 2nd wk 3rd wk 4th wk 2nd mnth
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 2 2 1 1 1
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 2 2 2 2 2
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
2 2 2 2 2 2 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 1 1 1 2 2
0 0 0 0 0 0 0 0 0 0 0
1 2 2 2 2 2 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
2 2 2 2 2 2 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
                                                                                             COUGH                                                                      EARACHE                                                                  EAR FULLNESS
4th mnth 6th mnth 1st wk 2nd wk 3rd wk 4th wk 2nd mnth 4th mnth 6th mnth 1st wk 2nd wk
0 0
0 0
1 1
0 0
0 0
0 0
0 0
0 0 2 2 2 2 2 2 2 2 2
0 0 1 1
2 2
0 0
0 0
0 0 1 1 1 1 2 2 2 2 2
0 0
0 0
0 0
2 2
0 0 2 2
0 0
0 0 1 1
0 0 2 2
0 0
0 0 0 0
0 0
0 0
0 0
0 0 2 2
0 0
0 0 2 2
0 0
                                                                 EAR FULLNESS
3rd wk 4th wk 2nd mnth 4th mnth 6th mnth
2 2 2 2 2
1 1 2 2 2
2 1 1 1 1
2 2 2 2 2
1 1 1 2 2
2 2 2 2 2
1 1 1 1 1
2 2 2 2 2
2 2 2 2 2
